Help mewith my 2nd year mbbs exams broo
2nd year MBBS high yield topics pathology pharmacology microbiology university exams India
https://www.doctutorials.com/mbbs-curriculum/mbbs-2nd-year-sβ¦
Library available: Robbins Basic & Cotran Pathology | Goodman & Gilman's + Katzung + Lippincott Pharmacology | Jawetz + Sherris Microbiology
| Topic | Why High-Yield |
|---|---|
| Cell Injury & Death | Apoptosis vs necrosis, types of necrosis (caseous, liquefactive, coagulative) |
| Inflammation | Acute vs chronic, mediators (histamine, prostaglandins, cytokines), granuloma formation |
| Wound Healing | Primary vs secondary intention, factors affecting healing |
| Neoplasia | Benign vs malignant, tumor markers, proto-oncogenes, carcinogenesis |
| Hemodynamic Disorders | Edema, thrombosis, embolism, infarction, shock |
| Amyloidosis | Types (AA, AL), Congo red staining, apple-green birefringence |
| Immune Pathology | Hypersensitivity reactions (Type I-IV), autoimmune diseases (SLE, RA) |
| Topic | Key Facts |
|---|---|
| Myocardial Infarction | Zones of MI, histological changes at 0h/6h/24h/1wk/2wk |
| Glomerulonephritis | Nephrotic vs nephritic syndrome, membranous GN, PSGN |
| Liver Pathology | Cirrhosis, hepatitis, portal hypertension |
| Lung Pathology | Pneumonia (lobar vs broncho), TB pathology, bronchiectasis |
| Blood | Anemias (iron deficiency, megaloblastic, hemolytic), leukemias |
| Cervical Carcinoma | Pap smear, CIN grading, HPV association |
| System | High-Yield Topics |
|---|---|
| ANS | Cholinomimetics, anticholinergics, adrenergic agonists/antagonists - mechanism + uses |
| CVS | Antihypertensives (ACE inhibitors, beta-blockers, CCBs), antiarrhythmics, digoxin toxicity |
| CNS | Opioid analgesics, sedative-hypnotics (benzodiazepines), antiepileptics, antipsychotics |
| Antimicrobials | Penicillins, cephalosporins, aminoglycosides, fluoroquinolones - MOA, spectrum, resistance |
| Autocoids | Histamine & antihistamines, NSAIDs, prostaglandins |
| Endocrine | Insulin types, oral hypoglycemics (metformin MOA), thyroid drugs, corticosteroids |
| General Pharmacology | Pharmacokinetics (ADME), dose-response curves, drug interactions, adverse effects |
| Topic | Key Points |
|---|---|
| Staph aureus | Virulence factors, MRSA, food poisoning, scalded skin syndrome |
| Streptococci | Strep pyogenes (Group A) - rheumatic fever, Strep pneumoniae - meningitis/pneumonia |
| E. coli | Serotypes, ETEC, EPEC, UTI pathogen, lab identification |
| Mycobacterium TB | Ghon complex, Koch phenomenon, lab diagnosis (ZN stain), drug resistance |
| Salmonella/Shigella | Typhoid fever, dysentery, Widal test |
| Clostridium | Gas gangrene, tetanus (toxin mechanism), botulism |
| Topic | Key Points |
|---|---|
| HIV | Replication, CD4 count, AIDS-defining conditions, antiretroviral drugs |
| Hepatitis viruses | A/B/C/D/E - serological markers (HBsAg, anti-HBc), chronicity |
| Herpes viruses | HSV, VZV, CMV, EBV - clinical syndromes |
| Sterilization & Disinfection | Methods, autoclave parameters, antiseptics vs disinfectants |
| Fungi | Candida, Cryptococcus, Aspergillus - morphology, lab diagnosis |
| Subject | Primary | Revision |
|---|---|---|
| Pathology | Robbins Basic Pathology | Geetika Khanna / Harsh Mohan |
| Pharmacology | KD Tripathi | Lippincott Illustrated Reviews (in library) |
| Microbiology | Jawetz (in library) | Paniker / Ananthanarayan |
Firstly bro, today is 29th June and I have internals on 13th July. So I probably have 10 days or minimum like that, 10 to 12 or 13 days maybe, in the middle of the, for the preparation. And I did not complete my records yet, so I can manage writing records in the class itself, like okay. So now, I didn't study a single word. I don't know a single word from these subjects. So give me a schedule. I have classes from morning 8:30 to 4:30. So plan the schedule from 6:30 to night 12 o'clock or 12:30, 12 hours. Okay, so yeah.
| Time | Activity |
|---|---|
| 6:30 - 8:00 AM | Morning Study Block (1.5 hrs) - Previous night's quick revision |
| 8:30 - 4:30 PM | Classes (attend, pay attention - free content!) |
| 4:30 - 5:00 PM | 30 min break + food |
| 5:00 - 7:00 PM | Evening Block 1 (2 hrs) - New topic, read + notes |
| 7:00 - 8:00 PM | Dinner + rest |
| 8:00 - 10:00 PM | Evening Block 2 (2 hrs) - Continue or new topic |
| 10:00 - 10:15 PM | Short break |
| 10:15 PM - 12:15 AM | Night Block (2 hrs) - MCQs + short notes revision |
| 12:15 - 12:30 AM | Write 5 key points in a diary (memory anchor) |
| Day | Date | Topics | Focus |
|---|---|---|---|
| Day 1 | Jun 29 (Today) | Cell Injury - causes, reversible vs irreversible injury, necrosis types | Evening + Night |
| Day 2 | Jun 30 | Apoptosis, Intracellular accumulations, Calcification | Full day blocks |
| Day 3 | Jul 1 | Acute Inflammation - mediators, exudates, outcomes | Full day blocks |
| Day 4 | Jul 2 | Chronic Inflammation + Granuloma + Wound Healing | Full day blocks |
| Day 5 | Jul 3 | Neoplasia (Benign vs Malignant, Tumor markers, Carcinogenesis) + Pathology Revision | Full day - revise Days 1-4 too |
| Day | Date | Topics | Focus |
|---|---|---|---|
| Day 6 | Jul 4 | General Micro (Sterilization + Disinfection + Bacterial structure) + Staph aureus + Streptococci | Full day blocks |
| Day 7 | Jul 5 | Gram negatives - E. coli, Salmonella, Shigella, Klebsiella | Full day blocks |
| Day 8 | Jul 6 | Mycobacterium TB (full) + Clostridium (tetanus, gas gangrene, botulism) | Full day blocks |
| Day 9 | Jul 7 | HIV + Hepatitis A/B/C + Herpes group + Micro Revision | Full day - revise Days 6-8 too |
| Day | Date | Topics | Focus |
|---|---|---|---|
| Day 10 | Jul 8 | General Pharmacology (PK/PD, ADME, dose-response) + ANS - cholinergic drugs | Full day blocks |
| Day 11 | Jul 9 | ANS - adrenergic drugs + CVS drugs (antihypertensives, antiarrhythmics, digoxin) | Full day blocks |
| Day 12 | Jul 10 | CNS drugs (opioids, sedatives, antiepileptics) + Antimicrobials (penicillin, aminoglycosides, fluoroquinolones) + NSAIDs | Full day blocks |
| Day | Date | Activity |
|---|---|---|
| Day 13 | Jul 11 | Pathology full revision - only short notes + important questions. Write answers once |
| Day 14 | Jul 12 | Micro + Pharma full revision - MCQs, previous year Q formats, stains, drug names |
| Day 15 | Jul 13 | EXAM DAY - Morning block only: read your diary notes. No new topics. |
Actually, I have a folder five days for each subject, right? And by the way, I don't have read any single word, and I don't know anything from everything about the subject. So I planned, I have super 50 questions, like 50 important questions from each subject, like paper 1 and paper 2. So each subject has 100 important questions. So I thought of completing them first, but my friend said, first complete PYQs first. I don't know which thing I should have followed. Like, should I complete PYQs first or the important 100 hard questions? Actually, I thought this is just an interview, so they don't follow the daylights that were given by the university to interview you on their choice, right? So I thought like that, and I want to prepare that 100 important questions. So just me, what should I do?
These are paper 1 and 2 super 50 questions i wnat yo start with micto btw
python3 -c " import pdfplumber files = [ '/home/daytona/workspace/attachments/64666b7f-e27a-473e-9a2a-057272e3b24b/NTRUHS 2K23 MICROBIOLOGY PAPER-1 SUPER-50.pdf', '/home/daytona/workspace/attachments/64666b7f-e27a-473e-9a2a-057272e3b24b/NTRUHS 2K23 MICROBIOLOGY PAPER-2 SUPER-50.pdf' ] for f in files: print('='*60) print(f) print('='*60) with pdfplumber.open(f) as pdf: for i, page in enumerate(pdf.pages): text = page.extract_text() if text: print(f'--- Page {i+1} ---') print(text) "
| Topic | Appears In |
|---|---|
| Taenia Solium | P1 Q15 + P2 Q6 (exact same!) |
| Hepatitis B/C | P1 Q17 + AETCOM P1 Q2 + AETCOM P2 Q5,6 |
| HIV | P1 Q7 + AETCOM P2 Q1,7 |
| Malaria/Cerebral Malaria | P1 Q9 + P2 Q25 |
| Syphilis/STIs | P2 Q1 + P2 Q11 |
| Meningitis | P2 Q8 (covers bacterial + TB + crypto) |
| Kala Azar | P1 Q10 (Leishmania) + P1 Q30 |
| Day | Date | Morning 6:30-8AM | Evening 5-7PM | Night 8-12AM |
|---|---|---|---|---|
| Day 1 | Jun 29 | - | Sterilization + Hypersensitivity Rxns + ELISA | HIV/AIDS full + Hepatitis B/C |
| Day 2 | Jun 30 | Revise Day 1 | Typhoid + Cholera + Shigella (GI bugs together) | TB full + Drug resistance |
| Day 3 | Jul 1 | Revise Day 2 | Strep pyogenes + Staph (MRSA) + Diphtheria | Malaria + Dengue + Rabies |
| Day 4 | Jul 2 | Revise Day 3 | Syphilis + Gonorrhea + all STIs together | Bacterial Meningitis + Tetanus + Gas gangrene |
| Day 5 | Jul 3 | Revise Day 4 | Parasites: Taenia, Malaria, Filaria, Ascaris, Hookworm | Short notes blitz: all Tier 3 topics + AETCOM template |
Can you please make time table from july 1st because i didn't completed my records so i had to write and i didn't follow the time table so i thought of starting from july 1st properly and from 13th july i have internals plan wisely to cover these
| Slot | Time | Duration | Purpose |
|---|---|---|---|
| π Morning | 6:30 - 8:00 AM | 1.5 hrs | Revise PREVIOUS night's topics |
| π« Classes | 8:30 - 4:30 PM | - | Attend + pay attention |
| π½οΈ Break | 4:30 - 5:00 PM | 30 min | Food + rest |
| π Evening | 5:00 - 7:00 PM | 2 hrs | New topic - read + write notes |
| π Dinner | 7:00 - 8:00 PM | 1 hr | Eat + rest |
| π Night 1 | 8:00 - 10:00 PM | 2 hrs | Continue topic or next topic |
| β Break | 10:00 - 10:15 PM | 15 min | - |
| π Night 2 | 10:15 PM - 12:15 AM | 2 hrs | MCQs + short notes writing |
| βοΈ Wind down | 12:15 - 12:30 AM | 15 min | Write 5 key points in diary |
You have 100 questions across 2 papers. Focus = Tier 1 first, then Tier 2, then short notes.
| Day | Date | Evening Block (5-7 PM) | Night Block 1 (8-10 PM) | Night Block 2 (10:15-12:15 AM) |
|---|---|---|---|---|
| Day 1 | Tue Jul 1 | Sterilization & Disinfection (P1 Q5) + ELISA (P1 Q3) | HIV/AIDS - structure, pathogenesis, lab diagnosis, ART (P1 Q7) | Hypersensitivity Reactions Type I-IV (P1 Q4) |
| Day 2 | Wed Jul 2 | Typhoid - pathogenesis, Widal test, lab diagnosis (P1 Q6) + Cholera (P1 Q37) + Shigella/Dysentery (P1 Q44) | Tuberculosis - full (P2 Q12) + Drug resistance (P1 Q21) | Hepatitis A/B/C/D/E - serology markers, prophylaxis (P1 Q17) |
| Day 3 | Thu Jul 3 | Strep pyogenes + complications (P2 Q7, Q16) + Diphtheria (P2 Q2) + MRSA (P1 Q31) | Malaria full + Cerebral malaria (P1 Q9, P2 Q25) + Dengue (P1 Q8) | Rabies - morphology, pathogenesis, PEP (P2 Q3) + Tetanus (P2 Q14) + Gas gangrene (P1 Q45) |
| Day 4 | Fri Jul 4 | Syphilis full + STI classification (P2 Q11) + Gonorrhea (P2 Q1) | Bacterial Meningitis - lab diagnosis, TB meningitis, Cryptococcal (P2 Q8) + Polio (P2 Q4) + Influenza/H1N1 (P2 Q5) | Autoimmunity + SLE (P1 Q1) + Antigen-Antibody reactions + Agglutination (P1 Q2) + Complement pathways (P1 Q28) |
| Day 5 | Sat Jul 5 | Parasites: Taenia Solium (P1 Q15 = P2 Q6) + Ascaris (P1 Q16) + Hookworm (P1 Q24) + Filaria (P1 Q11) | More Parasites: Entamoeba + Amoebic liver abscess (P1 Q12, Q34) + Giardia (P1 Q13) + Leishmania (P1 Q10) | Short notes blitz: Leptospirosis, Brucellosis, Aspergillosis, Plague, Anthrax, Pertussis, Mumps + AETCOM template |
General Pathology first - it's the most scoring and most asked.
| Day | Date | Evening (5-7 PM) | Night 1 (8-10 PM) | Night 2 (10:15-12:15 AM) |
|---|---|---|---|---|
| Day 6 | Sun Jul 6 | Cell Injury - causes, reversible vs irreversible, types of necrosis (coagulative, liquefactive, caseous, fat, fibrinoid) | Apoptosis - intrinsic vs extrinsic pathway, differences from necrosis + Intracellular accumulations (fatty change, hemosiderin, amyloid) | Inflammation - acute inflammation, vascular + cellular events, chemical mediators |
| Day 7 | Mon Jul 7 | Chronic Inflammation + Granuloma formation (TB, sarcoid, foreign body) | Wound Healing - primary vs secondary intention, factors affecting + Edema - mechanisms, types | Thrombosis + Embolism + Infarction - types, consequences |
| Day 8 | Tue Jul 8 | Neoplasia - benign vs malignant differences, carcinogenesis, oncogenes, tumor suppressor genes, tumor markers | Shock - types, stages, pathogenesis, morphological changes | Amyloidosis - types (AA, AL), Congo red stain, apple-green birefringence + Hemodynamic disorders revision |
| Day 9 | Wed Jul 9 | Systemic - CVS: MI histology (timeline 0h to weeks), atherosclerosis + Respiratory: Pneumonia (lobar vs broncho), TB pathology | Systemic - Kidney: Nephrotic vs Nephritic syndrome, PSGN, membranous GN + Liver: Cirrhosis, portal hypertension, hepatitis | Blood: Anemias (iron deficiency, megaloblastic, hemolytic - differences) + Leukemia classification |
| Day 10 | Thu Jul 10 | Female Genital: Cervical carcinoma, CIN grading, HPV + Endometrial carcinoma | Immune Pathology - SLE (pathology), RA + Hypersensitivity (pathology angle) | Pathology Stains revision (Congo red, ZN, PAS, Prussian blue, H&E findings) + short notes: all remaining topics |
Only 2 days so it's HIGH YIELD ONLY - no time for full coverage.
| Day | Date | Evening (5-7 PM) | Night 1 (8-10 PM) | Night 2 (10:15-12:15 AM) |
|---|---|---|---|---|
| Day 11 | Fri Jul 11 | General Pharmacology - pharmacokinetics (ADME), pharmacodynamics, dose-response curve, drug interactions, adverse effects | ANS - cholinergic agonists/antagonists + adrenergic agonists/antagonists + Organophosphate poisoning + atropine | CVS - antihypertensives (ACE-I, beta blockers, CCBs, diuretics) + Digoxin (MOA, toxicity) + antiarrhythmics |
| Day 12 | Sat Jul 12 | CNS - opioid analgesics (morphine), benzodiazepines, antiepileptics (phenytoin, valproate) + antipsychotics | Antimicrobials - Penicillin MOA + resistance + beta-lactamase, Aminoglycosides, Fluoroquinolones, Tetracyclines | NSAIDs + Corticosteroids + Insulin preparations + Oral hypoglycemics (metformin) + short notes revision |
| Time | Activity |
|---|---|
| 6:30 - 8:00 AM | Read ONLY your written short notes + diary key points. No new topics. |
| During exam | Write headings first for every answer, then fill content |
I couldn't get to start prep from july 1st because of records can you adjust the time Table from july 3rd
| Slot | Time | Duration | Purpose |
|---|---|---|---|
| π Morning | 6:30 - 8:00 AM | 1.5 hrs | Revise previous night's topics ONLY |
| π« Classes | 8:30 - 4:30 PM | β | Attend, listen carefully |
| π½οΈ Break | 4:30 - 5:00 PM | 30 min | Food + rest |
| π Evening | 5:00 - 7:00 PM | 2 hrs | New topic - read + write notes |
| π Dinner | 7:00 - 8:00 PM | 1 hr | Rest |
| π Night 1 | 8:00 - 10:00 PM | 2 hrs | Continue / next topic |
| β Break | 10:00 - 10:15 PM | 15 min | β |
| π Night 2 | 10:15 PM - 12:15 AM | 2 hrs | Short notes + MCQs |
| βοΈ Wind down | 12:15 - 12:30 AM | 15 min | Write 5 key points in diary |
Compressed from 5 to 3 days. Tier 1 topics only. Short notes for the rest.
| Day | Date | Evening (5-7 PM) | Night 1 (8-10 PM) | Night 2 (10:15-12:15 AM) |
|---|---|---|---|---|
| Day 1 | Fri Jul 3 | Sterilization (P1 Q5) + ELISA (P1 Q3) + Hypersensitivity Type I-IV (P1 Q4) | HIV/AIDS - structure, pathogenesis, lab diagnosis, ART, PEP (P1 Q7) | Hepatitis A/B/C - serology markers, HBsAg, prophylaxis (P1 Q17) |
| Day 2 | Sat Jul 4 | Typhoid full - pathogenesis, Widal, lab diagnosis (P1 Q6) + Cholera (P1 Q37) + Shigella/Dysentery (P1 Q44) | TB full - Ghon complex, pathogenesis, ZN stain, molecular diagnosis, TST (P2 Q12) + Drug resistance (P1 Q21) | Strep pyogenes + post-strep complications (P2 Q7, Q16) + Diphtheria (P2 Q2) + MRSA (P1 Q31) |
| Day 3 | Sun Jul 5 | Malaria full + Cerebral malaria (P1 Q9, P2 Q25) + Dengue (P1 Q8) | Syphilis full + STI classification (P2 Q11) + Bacterial Meningitis - lab diagnosis, TB/Crypto meningitis (P2 Q8) | Short notes blitz: Rabies, Tetanus, Gas gangrene, Taenia Solium, Ascaris, Hookworm, Autoimmunity/SLE, Antigen-Antibody reactions + AETCOM template |
You get 4 days here - this is the most scoring subject so it deserves slightly more time.
| Day | Date | Evening (5-7 PM) | Night 1 (8-10 PM) | Night 2 (10:15-12:15 AM) |
|---|---|---|---|---|
| Day 4 | Mon Jul 6 | Cell Injury - causes, reversible/irreversible, all types of necrosis + Apoptosis vs necrosis | Acute Inflammation - vascular events, cellular events, chemical mediators (histamine, prostaglandins, cytokines) | Chronic Inflammation + Granuloma - TB granuloma, sarcoid, foreign body + Wound Healing |
| Day 5 | Tue Jul 7 | Neoplasia - benign vs malignant, carcinogenesis, oncogenes, tumor suppressors, tumor markers | Shock - types, stages, pathogenesis + Thrombosis, Embolism, Infarction + Amyloidosis (Congo red, AA vs AL) | Hemodynamic disorders + Edema + Intracellular accumulations (fatty change, hemosiderin) |
| Day 6 | Wed Jul 8 | Systemic CVS: MI histology timeline + Atherosclerosis + Respiratory: Lobar vs Bronchopneumonia, TB pathology | Kidney: Nephrotic vs Nephritic syndrome, PSGN, Membranous GN + Liver: Cirrhosis, portal hypertension | Blood: Iron deficiency vs Megaloblastic vs Hemolytic anemia + Leukemia types |
| Day 7 | Thu Jul 9 | Female genital: Cervical carcinoma, CIN grading, HPV link + Immune Pathology: SLE, RA (pathology angle) | Stains revision: Congo red, ZN, PAS, Prussian blue, H&E key findings | Remaining short notes + any weak topics from Days 4-6 |
High-yield only. Straight to the point.
| Day | Date | Evening (5-7 PM) | Night 1 (8-10 PM) | Night 2 (10:15-12:15 AM) |
|---|---|---|---|---|
| Day 8 | Fri Jul 10 | General Pharmacology - ADME, pharmacodynamics, dose-response, drug interactions, bioavailability | ANS - cholinergic drugs, anticholinergics, adrenergic agonists/antagonists, Organophosphate poisoning + atropine | CVS - ACE inhibitors, beta-blockers, CCBs, diuretics + Digoxin MOA + toxicity + antiarrhythmics |
| Day 9 | Sat Jul 11 | CNS - Morphine/opioids, benzodiazepines, antiepileptics (phenytoin, valproate), antipsychotics | Antimicrobials - Penicillin MOA + resistance, Aminoglycosides, Fluoroquinolones, Tetracyclines | NSAIDs + Corticosteroids + Insulin types + Metformin + quick short notes revision |
| Time | Activity |
|---|---|
| 6:30 - 8:00 AM | Micro short notes revision |
| 5:00 - 7:00 PM | Pathology short notes revision |
| 8:00 - 10:00 PM | Pharmacology short notes revision |
| 10:15 PM - 12:15 AM | Read your diary key points for ALL 3 subjects. Write model answers for 3 questions (one per subject) |
| Time | Activity |
|---|---|
| 6:30 - 8:00 AM | Read diary notes ONLY. No new topics. Eat well. Sleep by 12:30 the night before. |
| Subject | Minimum Survival Topics |
|---|---|
| Micro | HIV, TB, Typhoid, Hepatitis B, Hypersensitivity, Sterilization |
| Pathology | Cell injury + necrosis, Inflammation, Granuloma, Neoplasia, Shock, MI histology, Nephrotic syndrome |
| Pharmacology | General Pharma, ANS (atropine), Penicillin, NSAIDs, Insulin, Beta-blockers |
Are you sure that you gave pharma only 2 days and patho 4 days
| Subject | Topics Volume | Difficulty | Days I Gave | Should Be |
|---|---|---|---|---|
| Microbiology | Medium - factual, memorizable | Medium | 3 days | β Fine |
| Pathology | Medium - conceptual | Medium | 4 days | β οΈ Could be 3 |
| Pharmacology | HUGE - mechanisms, drugs, doses, side effects | Hardest | 2 days | β Way too less |
| Subject | Days | Dates |
|---|---|---|
| π΅ Microbiology | 3 days | Jul 3, 4, 5 |
| π΄ Pathology | 3 days | Jul 6, 7, 8 |
| π’ Pharmacology | 3 days | Jul 9, 10, 11 |
| π‘ Full Revision | 1 day | Jul 12 |
| π― Exam | β | Jul 13 |
Create corrected 3-3-3 day timetable for me
| Slot | Time | Duration | What To Do |
|---|---|---|---|
| π Morning | 6:30 - 8:00 AM | 1.5 hrs | Revise ONLY last night's topics |
| π« Classes | 8:30 - 4:30 PM | β | Attend + listen (professors hint exam topics) |
| π½οΈ Break | 4:30 - 5:00 PM | 30 min | Food + rest, no phone doom scrolling |
| π Evening | 5:00 - 7:00 PM | 2 hrs | New topic β read + write short notes |
| π Dinner | 7:00 - 8:00 PM | 1 hr | Eat + proper rest |
| π Night 1 | 8:00 - 10:00 PM | 2 hrs | Next topic β read + write |
| β Mini break | 10:00 - 10:15 PM | 15 min | Stretch, water |
| π Night 2 | 10:15 PM - 12:15 AM | 2 hrs | MCQs + short notes review |
| βοΈ Wind down | 12:15 - 12:30 AM | 15 min | Write 5 key points per topic in diary |
| Day | Date | Evening 5-7 PM | Night 1 8-10 PM | Night 2 10:15-12:15 AM |
|---|---|---|---|---|
| Day 1 | Fri Jul 3 | Sterilization & Disinfection (P1 Q5) + ELISA (P1 Q3) + Hypersensitivity Type I-IV (P1 Q4) | HIV/AIDS β structure, pathogenesis, lab diagnosis, ART, PEP, opportunistic infections (P1 Q7) | Hepatitis A/B/C/D/E β serology markers, HBsAg, anti-HBc, prophylaxis, Hep C (P1 Q17) |
| Day 2 | Sat Jul 4 | Typhoid β pathogenesis, Widal test, lab diagnosis, drug resistance (P1 Q6) + Cholera (P1 Q37) + Shigella/Bacillary dysentery (P1 Q44) | TB β Ghon complex, pathogenesis, ZN stain, molecular methods, TST, atypical mycobacteria (P2 Q12) + Drug resistance mechanisms (P1 Q21) | Strep pyogenes + post-strep complications/rheumatic fever (P2 Q7, Q16) + Diphtheria (P2 Q2) + MRSA (P1 Q31) |
| Day 3 | Sun Jul 5 | Malaria β life cycle, pathogenesis, lab diagnosis, cerebral malaria (P1 Q9, P2 Q25) + Dengue β pathogenesis, investigations (P1 Q8) | Syphilis full β primary/secondary, pathogenesis, lab diagnosis, RPR test (P2 Q11, Q39) + Bacterial Meningitis β lab diagnosis, TB meningitis, Cryptococcal meningitis (P2 Q8) + Gonorrhea + STI list (P2 Q1) | Short notes blitz: Rabies + PEP (P2 Q3), Tetanus (P2 Q14), Gas gangrene (P1 Q45), Taenia Solium (P1 Q15 = P2 Q6), Ascaris + Hookworm (P1 Q16, Q24), Autoimmunity/SLE (P1 Q1), Antigen-Antibody reactions (P1 Q2) + AETCOM template (covers all 13 AETCOM Qs) |
| Day | Date | Evening 5-7 PM | Night 1 8-10 PM | Night 2 10:15-12:15 AM |
|---|---|---|---|---|
| Day 4 | Mon Jul 6 | Cell Injury β causes, reversible vs irreversible, all 5 types of necrosis (coagulative, liquefactive, caseous, fat, fibrinoid) + Apoptosis β intrinsic/extrinsic pathway, differences from necrosis | Acute Inflammation β vascular events, cellular events, chemical mediators (histamine, prostaglandins, leukotrienes, cytokines, complement) | Chronic Inflammation + Granuloma β types (TB, sarcoid, foreign body), Langhans giant cell + Wound Healing β primary vs secondary intention, factors affecting healing |
| Day 5 | Tue Jul 7 | Neoplasia β benign vs malignant differences, carcinogenesis (initiation/promotion/progression), oncogenes, tumor suppressor genes (p53, Rb), tumor markers table | Shock β types (hypovolemic, septic, cardiogenic, neurogenic), stages, pathogenesis, morphological changes + Amyloidosis β AA vs AL, Congo red stain, apple-green birefringence | Thrombosis + Embolism + Infarction β types, Virchow's triad, red vs white infarct + Intracellular accumulations (fatty change, hemosiderin, calcification) |
| Day 6 | Wed Jul 8 | Systemic CVS: MI histology timeline (0h/6h/24h/1wk/2wk) + Atherosclerosis + Respiratory: Lobar vs Bronchopneumonia differences, TB pathology (Ghon focus, Simon focus) | Kidney: Nephrotic vs Nephritic syndrome comparison table, PSGN, Membranous GN + Liver: Cirrhosis types, portal hypertension, hepatitis morphology | Blood: Iron deficiency vs Megaloblastic vs Hemolytic anemia (comparison table) + Leukemia classification + Immune Pathology: SLE + RA pathology + stains quick revision (Congo red, ZN, PAS, Prussian blue) |
| Day | Date | Evening 5-7 PM | Night 1 8-10 PM | Night 2 10:15-12:15 AM |
|---|---|---|---|---|
| Day 7 | Thu Jul 9 | General Pharmacology β pharmacokinetics (ADME, half-life, bioavailability, Vd), pharmacodynamics (agonist/antagonist, dose-response curve, therapeutic index), drug interactions, adverse drug reactions | ANS β Cholinergic β direct + indirect acting, muscarinic/nicotinic, anticholinergics (atropine uses + toxicity) + Organophosphate poisoning β mechanism + management | ANS β Adrenergic β alpha/beta agonists (adrenaline, noradrenaline, dopamine, salbutamol), alpha/beta blockers (propranolol uses + contraindications) |
| Day 8 | Fri Jul 10 | CVS Drugs β antihypertensives (ACE inhibitors, ARBs, beta-blockers, CCBs, diuretics β MOA + key side effects) + Digoxin β MOA, uses, toxicity, interactions | Antiarrhythmics β class I-IV, Vaughan Williams classification + CNS Drugs β opioids (morphine MOA, uses, side effects, antidote naloxone), benzodiazepines (mechanism, uses, flumazenil) | Antiepileptics β phenytoin, valproate, carbamazepine (MOA + key side effects each) + Antipsychotics β typical vs atypical, chlorpromazine side effects + Antidepressants β SSRIs, TCAs |
| Day 9 | Sat Jul 11 | Antimicrobials β Penicillin (MOA, beta-lactamase resistance, extended spectrum), Cephalosporins (generations), Aminoglycosides (MOA, ototoxicity, nephrotoxicity), Fluoroquinolones, Tetracyclines + Antitubercular drugs (HRZE β MOA + side effects) | NSAIDs β MOA, COX-1 vs COX-2, aspirin vs ibuprofen vs paracetamol, GI side effects + Corticosteroids β pharmacological effects, uses, side effects, contraindications | Endocrine β Insulin types (rapid/short/intermediate/long), Oral hypoglycemics (metformin MOA, SGLT2 inhibitors), Thyroid drugs + Pharmacology short notes revision β any remaining weak topics |
| Time | Activity |
|---|---|
| 6:30 - 8:00 AM | Read Micro diary notes β all key points |
| 5:00 - 6:30 PM | Read Pathology diary notes |
| 6:30 - 8:00 PM | Read Pharmacology diary notes |
| 8:00 - 10:00 PM | Write model answers for 3 questions β one per subject (practice writing, not just reading) |
| 10:15 PM - 12:00 AM | Go through ALL stains, tumor markers, drug side effects tables you made β pure recall practice |
| 12:00 AM | Sleep. Seriously. |
| Time | Activity |
|---|---|
| 6:30 - 8:00 AM | Diary notes only. No new topics. Eat a proper breakfast. |
| Subject | Drop These | Keep These |
|---|---|---|
| Micro | Parasites detail, rare short notes | HIV, TB, Typhoid, Hepatitis B, Hypersensitivity, Sterilization |
| Pathology | Systemic topics detail | Cell injury, Inflammation, Granuloma, Neoplasia, Shock, Amyloidosis |
| Pharmacology | Antidepressants, antipsychotics | General Pharma, ANS, Penicillin, NSAIDs, Insulin, Beta-blockers |
Going priority wise right??and identify whether it is 5-MARKS question or 10-marks question
| Priority | Q# | Topic | Marks |
|---|---|---|---|
| βββ TIER 1 | Q7 | HIV/AIDS β structure, pathogenesis, lab diagnosis, ART, PEP | 10 marks |
| βββ TIER 1 | Q4 | Hypersensitivity Reactions Type I-IV + Shwartzman reaction | 10 marks |
| βββ TIER 1 | Q6 | Typhoid/Enteric Fever β pathogenesis, Widal, lab diagnosis | 10 marks |
| βββ TIER 1 | Q17 | Hepatitis viruses β classification, morphology, serology, Hep B prophylaxis, Hep C | 10 marks |
| βββ TIER 1 | Q1 | Autoimmunity β mechanisms, SLE classification | 10 marks |
| βββ TIER 1 | Q5 | Sterilization β all methods, autoclave, disinfectants | 10 marks |
| βββ TIER 1 | Q9 | Malaria β life cycle, pathogenesis, lab diagnosis, cerebral malaria | 10 marks |
| ββ TIER 2 | Q2 | Antigen-Antibody reactions, agglutination, monoclonal antibodies | 10 marks |
| ββ TIER 2 | Q21 | Drug resistance mechanisms in bacteria | 10 marks |
| ββ TIER 2 | Q8 | Dengue β pathogenesis, clinical features, investigations | 10 marks |
| ββ TIER 2 | Q23 | Immune response β cell mediated immunity + active/passive/innate/acquired | 10 marks |
| ββ TIER 2 | Q3 | ELISA | 5 marks |
| ββ TIER 2 | Q28 | Alternative + Classical complement pathway | 5 marks |
| ββ TIER 2 | Q31 | MRSA | 5 marks |
| ββ TIER 2 | Q37 | Cholera | 5 marks |
| β TIER 3 | Q10 | Leishmaniasis β life cycle, lab diagnosis | 5 marks |
| β TIER 3 | Q11 | Bancroftian Filariasis β life cycle, pathogenesis | 5 marks |
| β TIER 3 | Q16 | Ascaris lumbricoides | 5 marks |
| β TIER 3 | Q24 | Hookworm (case-based) β mode, life cycle, complications | 5 marks |
| β TIER 3 | Q14 | Leptospirosis | 5 marks |
| β TIER 3 | Q18 | Enrichment media + Selective media | 5 marks |
| β TIER 3 | Q19 | Herpes zoster | 5 marks |
| β TIER 3 | Q20 | Campylobacter infections | 5 marks |
| β TIER 3 | Q22 | Diarrhoeagenic E. coli | 5 marks |
| β TIER 3 | Q25 | Dermatophytes / Dermatophytoses | 5 marks |
| β TIER 3 | Q26 | Moments of hand hygiene | 5 marks |
| β TIER 3 | Q27 | Anaerobic culture methods | 5 marks |
| β TIER 3 | Q29 | Lab diagnosis of viral + fungal infections | 5 marks |
| β TIER 3 | Q30 | Lab diagnosis of Brucellosis + Kala azar | 5 marks |
| β TIER 3 | Q32 | Blood culture methods β Infective Endocarditis | 5 marks |
| β TIER 3 | Q33 | Structure + functions of IgM, IgA, IgG | 5 marks |
| β TIER 3 | Q34 | Amoebic liver abscess | 5 marks |
| β TIER 3 | Q35 | Allograft reaction + GVHD | 5 marks |
| β TIER 3 | Q36 | Cysticercus Cellulosae | 5 marks |
| β TIER 3 | Q38 | Varicella zoster virus | 5 marks |
| β TIER 3 | Q39 | Actinomycosis + Mycetoma | 5 marks |
| β TIER 3 | Q40 | Leprosy + lab diagnosis | 5 marks |
| β TIER 3 | Q41 | Larva migrans | 5 marks |
| β TIER 3 | Q42 | Toxic shock syndrome | 5 marks |
| β TIER 3 | Q43 | Viral gastroenteritis | 5 marks |
| β TIER 3 | Q44 | Bacillary dysentery β pathogenesis + lab diagnosis | 5 marks |
| β TIER 3 | Q45 | Gas gangrene | 5 marks |
| β TIER 3 | Q46 | Enterobius Vermicularis | 5 marks |
| β TIER 3 | Q47 | Helicobacter Pylori | 5 marks |
| β TIER 3 | Q48 | Staph food poisoning (case-based) β Chinese fried rice | 5 marks |
| β TIER 3 | Q49 | Louis Pasteur + Robert Koch | 5 marks |
| β TIER 3 | Q50 | Standard / Universal Precautions | 5 marks |
| π AETCOM | β | Communication scenarios (all 8 Qs) | 5 marks each |
| Priority | Q# | Topic | Marks |
|---|---|---|---|
| βββ TIER 1 | Q12 | Tuberculosis β pathogenesis, molecular methods, TST, atypical mycobacteria | 10 marks |
| βββ TIER 1 | Q7 | Streptococcus pyogenes | 10 marks |
| βββ TIER 1 | Q8 | Bacterial Meningitis β lab diagnosis, TB/Crypto/Meningococcal meningitis | 10 marks |
| βββ TIER 1 | Q11 | Syphilis β primary/secondary, pathogenesis, lab diagnosis | 10 marks |
| βββ TIER 1 | Q1 | Gonorrhea β pathogenesis, clinical features, STI classification | 10 marks |
| βββ TIER 1 | Q3 | Rabies β morphology, pathogenesis, lab diagnosis, PEP | 10 marks |
| ββ TIER 2 | Q2 | Diphtheria | 10 marks |
| ββ TIER 2 | Q4 | Polio virus β OPV vs IPV differences | 10 marks |
| ββ TIER 2 | Q5 | Influenza / Swine flu / H1N1 β diagnosis + prophylaxis | 10 marks |
| ββ TIER 2 | Q9 | Cestodes β Echinococcus granulosus life cycle + pathogenesis | 10 marks |
| ββ TIER 2 | Q10 | Urinary tract infections β lab diagnosis | 5 marks |
| ββ TIER 2 | Q14 | Clostridium tetani + tetanus prevention | 5 marks |
| ββ TIER 2 | Q16 | Complications of post-streptococcal infection | 5 marks |
| ββ TIER 2 | Q22 | Bacillus anthracis β cutaneous + pulmonary anthrax | 5 marks |
| ββ TIER 2 | Q23 | Aspergillosis | 5 marks |
| ββ TIER 2 | Q25 | Cerebral malaria | 5 marks |
| ββ TIER 2 | Q45 | Brucellosis + lab diagnosis | 5 marks |
| β TIER 3 | Q6 | Taenia Solium (same as P1 Q15) | 5 marks |
| β TIER 3 | Q13 | Plague β clinical types | 5 marks |
| β TIER 3 | Q15 | COVID-19 β pathogenesis | 5 marks |
| β TIER 3 | Q17 | Satellitism | 5 marks |
| β TIER 3 | Q18 | Pneumocystis pneumonia | 5 marks |
| β TIER 3 | Q19 | Anaerobic vaginosis | 5 marks |
| β TIER 3 | Q20 | Lymphogranuloma venereum | 5 marks |
| β TIER 3 | Q24 | Slow viral infections | 5 marks |
| β TIER 3 | Q26 | Neurocysticercosis | 5 marks |
| β TIER 3 | Q27 | Chancroid | 5 marks |
| β TIER 3 | Q28 | Acute Pyelonephritis β causative organisms + pathogenesis | 5 marks |
| β TIER 3 | Q29 | Naegleria fowleri | 5 marks |
| β TIER 3 | Q30 | Infection control policy | 5 marks |
| β TIER 3 | Q31 | Elek's gel precipitation test | 5 marks |
| β TIER 3 | Q32 | Toxoplasma gondii β morphology + life cycle | 5 marks |
| β TIER 3 | Q33 | Trichomonas vaginalis | 5 marks |
| β TIER 3 | Q35 | Atypical pneumonia / Mycoplasma | 5 marks |
| β TIER 3 | Q36 | Oncogenic viruses | 5 marks |
| β TIER 3 | Q37 | Histoplasmosis | 5 marks |
| β TIER 3 | Q38 | Viral hemorrhagic fevers | 5 marks |
| β TIER 3 | Q39 | RPR test | 5 marks |
| β TIER 3 | Q40 | Japanese B Encephalitis | 5 marks |
| β TIER 3 | Q41 | Paragonimiasis | 5 marks |
| β TIER 3 | Q42 | Prions | 5 marks |
| β TIER 3 | Q43 | Non-gonococcal urethritis | 5 marks |
| β TIER 3 | Q44 | Borrelia Vincenti | 5 marks |
| β TIER 3 | Q46 | Zygomycosis + Opportunistic Mycoses | 5 marks |
| β TIER 3 | Q47 | Congenital rubella syndrome | 5 marks |
| β TIER 3 | Q48 | Tularemia | 5 marks |
| β TIER 3 | Q49 | Mumps | 5 marks |
| β TIER 3 | Q50 | Pertussis (Whooping cough) | 5 marks |
| If a question has... | It's likely... |
|---|---|
| Multiple sub-parts (pathogenesis + lab + treatment + prevention) | 10 marks |
| Single focus (just morphology, or just lab diagnosis, or just one aspect) | 5 marks |
| "Classify... describe... add a note on..." structure | 10 marks |
| Just a name or short topic | 5 marks |
Okayy now include these questions into the time Table and now the time is 5 pm so which questions should i read first
| Time | What to Study | Q# | Marks |
|---|---|---|---|
| 5:00 - 7:00 PM β YOU ARE HERE | Sterilization + Disinfection + Autoclave + Chemical disinfectants | P1 Q5 | 10 marks |
| 8:00 - 10:00 PM | HIV/AIDS β structure, pathogenesis, lab diagnosis, ART, PEP | P1 Q7 | 10 marks |
| 10:15 PM - 12:15 AM | Hepatitis A/B/C/D/E β serology, HBsAg markers, prophylaxis | P1 Q17 | 10 marks |
| 6:30 AM tomorrow | Revise all 3 topics from tonight |
| Day | Evening 5-7 PM | Night 1 8-10 PM | Night 2 10:15-12:15 AM |
|---|---|---|---|
| Fri Jul 3 | βββ Sterilization + Disinfection (P1 Q5) 10m | βββ HIV/AIDS full (P1 Q7) 10m | βββ Hepatitis A/B/C/D/E (P1 Q17) 10m |
| Sat Jul 4 | βββ Hypersensitivity Type I-IV + Shwartzman (P1 Q4) 10m | βββ Typhoid full + Widal (P1 Q6) 10m | βββ TB full + molecular methods + TST (P2 Q12) 10m |
| Sun Jul 5 | βββ Strep pyogenes + post-strep complications (P2 Q7, Q16) 10m + Diphtheria (P2 Q2) 10m | βββ Syphilis + STI classification (P2 Q11, Q1) 10m + Bacterial Meningitis (P2 Q8) 10m | ββ Drug resistance (P1 Q21) 10m + ELISA (P1 Q3) 5m + AETCOM template 5m each |
| Sun Jul 5 β Short notes | ββ Cholera (P1 Q37) 5m + MRSA (P1 Q31) 5m + Rabies + PEP (P2 Q3) 10m | β Malaria + Cerebral malaria (P1 Q9, P2 Q25) 10m + Dengue (P1 Q8) 10m | β Tetanus (P2 Q14) 5m + Gas gangrene (P1 Q45) 5m + Taenia Solium (P1 Q15) 5m + Ascaris + Hookworm (P1 Q16, Q24) 5m |
| Day | Evening 5-7 PM | Night 1 8-10 PM | Night 2 10:15-12:15 AM |
|---|---|---|---|
| Mon Jul 6 | βββ Cell Injury β necrosis types + Apoptosis 10m | βββ Acute Inflammation β mediators, vascular + cellular events 10m | βββ Chronic Inflammation + Granuloma 10m + Wound Healing 5m |
| Tue Jul 7 | βββ Neoplasia β carcinogenesis, oncogenes, tumor markers 10m | βββ Shock β types, stages, pathogenesis 10m + Amyloidosis β Congo red, AA vs AL 5m | ββ Thrombosis + Embolism + Infarction 10m + Intracellular accumulations 5m |
| Wed Jul 8 | βββ MI histology timeline + Atherosclerosis 10m + Lobar vs Bronchopneumonia 5m | βββ Nephrotic vs Nephritic syndrome + PSGN + Membranous GN 10m + Cirrhosis + Portal hypertension 5m | ββ Anemias comparison table 5m + Leukemia 5m + SLE pathology 5m + Stains table 5m |
| Day | Evening 5-7 PM | Night 1 8-10 PM | Night 2 10:15-12:15 AM |
|---|---|---|---|
| Thu Jul 9 | βββ General Pharmacology β ADME, PD, dose-response, drug interactions 10m | βββ ANS Cholinergic drugs + Anticholinergics + Organophosphate poisoning 10m | βββ Adrenergic agonists + antagonists (adrenaline, propranolol) 10m |
| Fri Jul 10 | βββ Antihypertensives β ACE-I, beta-blockers, CCBs, diuretics 10m + Digoxin 5m | ββ Antiarrhythmics 5m + Morphine/Opioids 10m + Benzodiazepines 5m | ββ Antiepileptics β phenytoin, valproate 5m + Antipsychotics 5m |
| Sat Jul 11 | βββ Penicillin β MOA, resistance, beta-lactamase 10m + Aminoglycosides + Fluoroquinolones 5m each | βββ NSAIDs β COX-1/2, aspirin vs ibuprofen 10m + Corticosteroids 5m | ββ Insulin types 5m + Metformin 5m + Antitubercular drugs HRZE 5m |
| Day | Activity |
|---|---|
| Sun Jul 12 | Morning: Micro notes. Evening: Patho notes. Night: Pharma notes + write 3 model answers |
| Mon Jul 13 | 6:30-8AM: Diary notes only. Then exam. |
So all questions from Super-50 included in this time Table right??
python3 -c " # Paper 1 questions p1 = [ 'Q1 - Autoimmunity, SLE', 'Q2 - Antigen-Antibody reactions, Agglutination, Monoclonal antibodies', 'Q3 - ELISA', 'Q4 - Hypersensitivity Reactions Type I-IV, Shwartzman', 'Q5 - Sterilization, Disinfection, Autoclave', 'Q6 - Typhoid/Enteric Fever, Widal test', 'Q7 - HIV/AIDS, ART, PEP, Opportunistic infections', 'Q8 - Dengue', 'Q9 - Malaria, Cerebral malaria', 'Q10 - Leishmaniasis/Kala azar', 'Q11 - Bancroftian Filariasis', 'Q12 - Entamoeba Histolytica', 'Q13 - Giardia lamblia', 'Q14 - Leptospirosis', 'Q15 - Taenia Solium', 'Q16 - Ascaris lumbricoides', 'Q17 - Hepatitis A/B/C/D/E, serology, prophylaxis', 'Q18 - Enrichment media, Selective media', 'Q19 - Herpes zoster', 'Q20 - Campylobacter infections', 'Q21 - Drug resistance mechanisms', 'Q22 - Diarrhoeagenic E. coli', 'Q23 - Immune response, CMI, Active/Passive/Innate/Acquired immunity', 'Q24 - Hookworm (case-based)', 'Q25 - Dermatophytes', 'Q26 - Moments of hand hygiene', 'Q27 - Anaerobic culture methods', 'Q28 - Complement pathways', 'Q29 - Lab diagnosis of viral and fungal infections', 'Q30 - Lab diagnosis of Brucellosis + Kala azar', 'Q31 - MRSA', 'Q32 - Blood culture methods, Infective Endocarditis', 'Q33 - IgM, IgA, IgG structure and functions', 'Q34 - Amoebic liver abscess', 'Q35 - Allograft reaction, GVHD', 'Q36 - Cysticercus Cellulosae', 'Q37 - Cholera', 'Q38 - Varicella zoster virus', 'Q39 - Actinomycosis, Mycetoma', 'Q40 - Leprosy, lab diagnosis', 'Q41 - Larva migrans', 'Q42 - Toxic shock syndrome', 'Q43 - Viral gastroenteritis', 'Q44 - Bacillary dysentery/Shigella', 'Q45 - Gas gangrene', 'Q46 - Enterobius vermicularis', 'Q47 - Helicobacter pylori', 'Q48 - Staph food poisoning (Chinese rice case)', 'Q49 - Louis Pasteur, Robert Koch', 'Q50 - Standard/Universal precautions', ] p2 = [ 'Q1 - Gonorrhea, STI classification', 'Q2 - Diphtheria', 'Q3 - Rabies, PEP, morphology', 'Q4 - Polio virus, OPV vs IPV', 'Q5 - Influenza, Swine flu, H1N1', 'Q6 - Taenia Solium (same as P1 Q15)', 'Q7 - Streptococcus pyogenes', 'Q8 - Bacterial Meningitis, TB meningitis, Cryptococcal meningitis', 'Q9 - Cestodes, Echinococcus granulosus', 'Q10 - UTI, lab diagnosis', 'Q11 - Syphilis, primary/secondary, lab diagnosis', 'Q12 - Tuberculosis full, molecular methods, TST', 'Q13 - Plague, clinical types', 'Q14 - Clostridium tetani, tetanus prevention', 'Q15 - COVID-19, pathogenesis', 'Q16 - Post-streptococcal complications', 'Q17 - Satellitism', 'Q18 - Pneumocystis pneumonia', 'Q19 - Anaerobic vaginosis', 'Q20 - Lymphogranuloma venereum', 'Q21 - Yersinia pestis (same as Plague)', 'Q22 - Bacillus anthracis, cutaneous/pulmonary anthrax', 'Q23 - Aspergillosis', 'Q24 - Slow viral infections', 'Q25 - Cerebral malaria (same as P1 Q9)', 'Q26 - Neurocysticercosis', 'Q27 - Chancroid', 'Q28 - Acute Pyelonephritis, pathogenesis', 'Q29 - Naegleria fowleri', 'Q30 - Infection control policy', 'Q31 - Eleks gel precipitation test', 'Q32 - Toxoplasma gondii', 'Q33 - Trichomonas vaginalis', 'Q34 - Primary amoebic encephalitis', 'Q35 - Atypical pneumonia, Mycoplasma', 'Q36 - Oncogenic viruses', 'Q37 - Histoplasmosis', 'Q38 - Viral hemorrhagic fevers', 'Q39 - RPR test', 'Q40 - Japanese B Encephalitis', 'Q41 - Paragonimiasis', 'Q42 - Prions', 'Q43 - Non-gonococcal urethritis', 'Q44 - Borrelia Vincenti', 'Q45 - Brucellosis, lab diagnosis', 'Q46 - Zygomycosis, Opportunistic mycoses', 'Q47 - Congenital rubella syndrome', 'Q48 - Tularemia', 'Q49 - Mumps', 'Q50 - Pertussis', ] print(f'Paper 1: {len(p1)} questions') print(f'Paper 2: {len(p2)} questions') print(f'Total: {len(p1)+len(p2)} questions') # Identify duplicates print() print('DUPLICATES (study once covers both):') print('- Taenia Solium: P1 Q15 = P2 Q6') print('- Cerebral Malaria: P1 Q9 (part of) = P2 Q25') print('- Kala azar: P1 Q10 = P1 Q30 (partial)') print('- Plague: P2 Q13 = P2 Q21 (Yersinia pestis)') print() print('Unique topics after dedup: ~96') "
| Count | |
|---|---|
| Total questions | 100 |
| Duplicates (same topic in both papers) | 4 |
| Unique topics to study | ~96 |
| 10-mark questions | ~20 |
| 5-mark questions | ~76 |
| Day | Focus | Topics Covered |
|---|---|---|
| Jul 3 (Today) | ALL 10-mark Tier 1 questions | HIV, Hepatitis, Sterilization, Hypersensitivity, Typhoid, TB |
| Jul 4 | Remaining 10-markers + top 5-markers | Strep, Syphilis, Meningitis, Gonorrhea, Rabies, Diphtheria, Polio, Influenza, Malaria, Dengue, Drug resistance, CMI |
| Jul 5 | All 5-mark short notes | Cholera, MRSA, Tetanus, Gas gangrene, Taenia, Ascaris, Hookworm, Brucellosis, Aspergillosis, Anthrax, UTI, Plague + rest |
Satellitism, Borrelia Vincenti, Tularemia, Paragonimiasis, Naegleria fowleri, Primary amoebic encephalitis, Elek's gel test, Slow viral infections, Zygomycosis, Neurocysticercosis, Toxoplasma, Trichomonas, Larva migrans, Enterobius, Campylobacter, Dermatophytes, Viral gastroenteritis, Anaerobic vaginosis, LGV, Chancroid, Non-gonococcal urethritis, Histoplasmosis, Prions, Congenital rubella, Mumps, Pertussis, Japanese B Encephalitis, Viral hemorrhagic fevers, Oncogenic viruses, COVID-19, Pneumocystis, Infection control policy, Robert Koch/Pasteur, Hand hygiene moments, Universal precautions
Start with sterilization notes right now (5 PM)
| Term | Definition | Key Point |
|---|---|---|
| Sterilization | Complete killing/removal of ALL living organisms including spores | Absolute term |
| Disinfection | Destruction of most pathogens but NOT all spores | Less precise than sterilization |
| Antisepsis | Use of chemical agents on living body surfaces (skin/mucosa) to reduce microbes | Safe for body use |
| Pasteurization | Heat at sub-sterilization temp to kill pathogenic organisms in liquids | Spores survive |
| Sanitization | Reduction of microbial load to safe public health levels | Used in food/housekeeping |
| Asepsis | Working system designed to PREVENT microorganisms from reaching a protected area | OR technique, lab work |
| Method | Temp | Time | What it kills |
|---|---|---|---|
| Autoclave (Steam under pressure) | 121Β°C | 15-20 min | Everything including spores β |
| Boiling | 100Β°C | 10-30 min | Vegetative bacteria, most viruses. NOT spores β |
| Pasteurization (HTST) | 72Β°C | 15 seconds | Pathogens in milk/liquids |
| Pasteurization (LTLT) | 62Β°C | 30 minutes | Same |
Autoclave working principle: Steam under pressure raises boiling point above 100Β°C. At 15 psi pressure β 121Β°C. This denatures proteins and kills ALL organisms including spores.
| Method | Temp | Time | Use |
|---|---|---|---|
| Hot air oven | 160Β°C | 1 hour | Glassware, oils, powders (can't use moist heat) |
| Incineration | Red heat | Instant | Inoculation loops, contaminated waste |
| Flaming | Red heat | Instant | Wire loops in lab |
Remember: Moist heat > Dry heat in efficiency (same temperature, moist heat works faster because steam penetrates better)
| Type | Mechanism | Use |
|---|---|---|
| UV light | Damages DNA (forms thymine dimers) | Air disinfection, OT surfaces, lab benches |
| Ionizing radiation (gamma rays, X-rays) | Breaks DNA strands | Sterilization of pre-packed disposables (syringes, catheters) |
UV light does NOT penetrate β only surface disinfection. Cannot sterilize liquids.
| Agent | MOA | Use | Key Fact |
|---|---|---|---|
| Glutaraldehyde (2%) | Alkylates proteins + DNA | Endoscopes, surgical instruments that can't be autoclaved | Instrument sterilization β 10 hrs contact |
| Formaldehyde | Alkylates proteins | Fumigation, preservation | Toxic, carcinogenic |
| Hydrogen Peroxide | Oxidizes cell components | Wounds, contact lenses, surfaces | "Plasma sterilization" |
| Peracetic acid | Strong oxidizer | Endoscopes | Fast-acting |
| Agent | MOA | Use |
|---|---|---|
| Alcohols (70% ethanol/isopropanol) | Denature proteins, disrupt membranes | Skin antisepsis, surface disinfection |
| Iodine/Iodophors (Betadine) | Oxidizes + precipitates proteins | Skin prep before surgery, wound cleaning |
| Chlorine compounds (hypochlorite/bleach) | Strong oxidizing agent | Water purification, surface disinfection, blood spills |
| Phenolic compounds | Disrupts lipid membranes β leakage of cell contents | Surface disinfection, lab benches |
| Agent | MOA | Use |
|---|---|---|
| Quaternary ammonium compounds (Benzalkonium chloride) | Denatures membranes | Non-critical surfaces (BP cuff, stethoscopes) |
| Agent | Use | Key Point |
|---|---|---|
| Ethylene oxide (ETO) | Heat-sensitive equipment β plastics, catheters, pacemakers | Slow process, 30% humidity needed. Carcinogenic β needs aeration after |
| Formaldehyde gas | Room/cabinet fumigation | Toxic |
| Level | Kills | Example |
|---|---|---|
| High | All organisms except some spores | Glutaraldehyde, HβOβ, Moist heat |
| Intermediate | Vegetative bacteria, TB, most viruses, fungi. NOT spores | Alcohols, Iodophors, Phenolics |
| Low | Most vegetative bacteria, some viruses. NOT TB, NOT spores | Quaternary ammonium compounds |
Does this and Anantha Narayan had a huge difference
| Aspect | My Notes (Sherris + Jawetz) | Ananthanarayan |
|---|---|---|
| Definitions | Same β Sterilization, Disinfection, Antisepsis, Asepsis | Same definitions, same words |
| Autoclave parameters | 121Β°C, 15 psi, 15-20 min | Same β 121Β°C, 15 lbs/psi, 15-20 min |
| Moist vs Dry heat | Same | Same |
| Chemical agents table | Same agents, same MOA | Same |
| Levels of disinfection | High/Intermediate/Low | Same classification |
| Resistance order | Prions > Spores > Mycobacteria... | Same order |
| Biological indicator | Geobacillus stearothermophilus | Same organism |
| ETO | Same parameters | Same |
The notes I gave you cover 95% of what Ananthanarayan covers on this topic. The 5% difference is minor brand names and extra detail that will NOT come in internals.
Can you give the sumary flow chart shortly of this question
STERILIZATION & DISINFECTION
β
βββ DEFINITIONS
β βββ Sterilization β kills ALL organisms (including spores) [ABSOLUTE]
β βββ Disinfection β kills MOST pathogens (spores may survive)
β βββ Antisepsis β disinfection on LIVING BODY surfaces
β βββ Pasteurization β kills pathogens in LIQUIDS (not spores)
β βββ Asepsis β PREVENTS entry of microbes
β
βββ METHODS
β β
β βββ PHYSICAL
β β β
β β βββ HEAT
β β β βββ MOIST HEAT (more efficient)
β β β β βββ β AUTOCLAVE β 121Β°C | 15 psi | 15-20 min β kills SPORES β
β β β β βββ Boiling β 100Β°C | 10-30 min β NO spores β
β β β β βββ Pasteurization β 72Β°C/15 sec OR 62Β°C/30 min
β β β β
β β β βββ DRY HEAT
β β β βββ Hot air oven β 160Β°C | 1 hour β glass, oils, powders
β β β βββ Incineration β loops, contaminated waste
β β β
β β βββ RADIATION
β β β βββ UV β thymine dimers β air/surface only (no penetration)
β β β βββ Ionizing (gamma) β breaks DNA β pre-packed disposables
β β β
β β βββ FILTRATION β 0.22 ΞΌm β heat-sensitive liquids (vaccines, sera)
β β β Does NOT remove viruses
β β
β βββ CHEMICAL
β β
β βββ HIGH LEVEL (can sterilize)
β β βββ Glutaraldehyde 2% β endoscopes, instruments
β β βββ Hydrogen peroxide β wounds, surfaces
β β βββ Peracetic acid β endoscopes (fast)
β β
β βββ INTERMEDIATE LEVEL
β β βββ Alcohol 70% β skin, surfaces (denatures proteins)
β β βββ Iodophors/Betadine β skin prep, wounds (oxidizes proteins)
β β βββ Chlorine/Bleach β water, blood spills (strong oxidizer)
β β βββ Phenolics β lab bench, surfaces (disrupts membranes)
β β
β βββ LOW LEVEL
β β βββ Quaternary ammonium (Benzalkonium Cl) β stethoscopes, BP cuffs
β β
β βββ GASEOUS
β βββ β Ethylene oxide (ETO) β plastics, catheters, pacemakers
β β (heat sensitive) needs 30% humidity
β βββ Formaldehyde gas β fumigation (toxic)
β
βββ AUTOCLAVE INDICATORS
β βββ Browne's tubes β red β green (chemical)
β βββ Bowie-Dick tape β color change (chemical)
β βββ β Geobacillus stearothermophilus spores (BIOLOGICAL = gold standard)
β
βββ FACTORS AFFECTING DISINFECTION
β βββ Concentration, Time, Temperature, pH
β βββ Organic matter β activity
β βββ Nature of organism
β
βββ β RESISTANCE ORDER (MCQ)
Prions > Spores > Mycobacteria > Non-enveloped virus
> Fungi > Vegetative bacteria > Enveloped virus
(Most resistant β Least resistant)
Temperatures are important???
| Method | Temp | Time | Kills |
|---|---|---|---|
| Autoclave | 121Β°C | 15-20 min | Everything + spores |
| Hot air oven | 160Β°C | 1 hour | Everything + spores |
| Boiling | 100Β°C | 10-30 min | Vegetative only, NO spores |
| Pasteurization HTST | 72Β°C | 15 seconds | Pathogens in milk |
| Pasteurization LTLT | 62Β°C | 30 minutes | Same |
| Inspissation | 80-85Β°C | 30 min Γ 3 days | Serum/egg media solidification |
| Tyndallization | 100Β°C | 30 min Γ 3 days | Kills spores by repeated heating |
AUTOCLAVE β 121Β°C | 15 psi | 15-20 min
HOT AIR OVEN β 160Β°C | 1 hour
PASTEURIZATION β 72Β°C | 15 sec (or 62Β°C | 30 min)
"1-2-1 rule" Autoclave = 121Β°C (read as one-two-one) Hot air oven = 160 = 121 + 39 more degrees needed because dry heat is weaker
Give mnemonics to remember the key points like classification and all of that don't give mnemonics in sentences give it in a word like take alla the first letters or the other way but it has to be simple and pronouncable
Chemical | Heat | Irradiation | Ethylene oxide (gas) | Filtration
Pasteurization | Autoclave | Boiling | Inspissation
15 psi | 121Β°C | 15-20 min
High | Intermediate | Low
Glutaraldehyde | Hydrogen peroxide | Alcohol (some classify here) | Peracetic acid
Alcohol | Iodophors | Chlorine | Phenolics
Formaldehyde | Ethylene oxide | Plasma (hydrogen peroxide plasma)
Concentration | Time | pH | Organic matter | Nature of organism | Temperature
Browne's tube | Bowie-Dick tape | Geobacillus (biological)
Prions | Spores | Mycobacteria | Non-enveloped virus | Fungi | Vegetative bacteria | Enveloped virus
P-S-M β "PSM" = "PRISM" (drop the RI)
N-F-V β "NFV" = "iNFoV" (info-v)
Oils | Lenses | Plastics (heat sensitive) | Heat-sensitive liquids
| What to remember | Mnemonic |
|---|---|
| All methods | CHEEF-G |
| Moist heat types | PABI |
| Autoclave numbers | 15-121-15 |
| Levels of disinfection | HIL (HILL) |
| High level agents | GHAP |
| Intermediate agents | AICP (AY-sip) |
| Gaseous agents | FEP |
| Factors affecting | CTPONT (SEE-PONT) |
| Indicators | BrBG |
| Resistance order top 3 | PSM = PRISM |
| Cannot autoclave | OLPH |
Give some mcqs on this question to test me
For one B 2C, 3C, 4C, 5B. Uh, 6D, 7C, 8B, 9C, 10B or D, 11th I don't know. 12C, 13, I don't know. 14B, 15, I don't know.
| Q | Your Answer | Correct | Result | Quick Explanation |
|---|---|---|---|---|
| 1 | B | B | β | 121Β°C, 15 psi, 15-20 min β classic autoclave |
| 2 | C | C | β | 160Β°C, 1 hour β hot air oven |
| 3 | C | C | β | Oils can't be penetrated by steam β hot air oven instead |
| 4 | C | C | β | Geobacillus stearothermophilus β gold standard |
| 5 | B | B | β | HTST = 72Β°C for 15 seconds |
| 6 | D | D | β | Prions β most resistant, top of PRISM |
| 7 | C | C | β | 2% Glutaraldehyde = endoscope sterilization |
| 8 | B | B | β | Thymine dimers in DNA β perfect |
| 9 | C | C | β | Benzalkonium chloride = quaternary ammonium = LOW level |
| 10 | B or D | B β | β 0.5 | B is the primary answer. D is wrong β ETO is NOT for air disinfection (UV is for air). Good instinct picking B first |
| 11 | Don't know | C | β | Phenolic compounds disrupt lipid membranes β cell contents leak out. Remember: Phenol = Pops membranes |
| 12 | C | C | β | Viruses too small (20-300nm) to be caught by 0.22ΞΌm filter |
| 13 | Don't know | B | β | Tyndallization = 100Β°C Γ 30 min Γ 3 consecutive days. Kills spores by repeated heating β spores germinate overnight, then killed next day as vegetative forms |
| 14 | B | B | β | Organic matter (blood/pus) neutralizes disinfectants β that's why we clean wounds before applying antiseptic |
| 15 | Don't know | C | β | BP cuff = non-critical instrument (touches skin only, not mucosa/sterile tissue) β Low level = Quaternary ammonium is enough |
Phenol β Pops the lipid membrane β cell contents leak out β bacteria die
Iodine β oxidizes proteins
Chlorine β strong oxidizer
Glutaraldehyde β alkylates DNA + proteins
Tyndallization = 100Β°C Γ 30 min Γ 3 DAYS in a row
Why 3 days?
Day 1: Heat kills vegetative bacteria. Spores SURVIVE.
Night 1: Spores germinate β become vegetative bacteria
Day 2: Heat kills those vegetative bacteria. More spores survive.
Night 2: Remaining spores germinate again
Day 3: Final heat kills ALL remaining vegetative forms
Result: Eventually all spores are killed without high pressure
| Category | Instrument | Example | Level Needed |
|---|---|---|---|
| Critical | Enters sterile tissue/blood | Surgical instruments, needles | Sterilization |
| Semi-critical | Touches mucous membranes | Endoscopes, bronchoscopes | High level |
| Non-critical | Touches intact skin only | BP cuff, stethoscope, ECG leads | Low level |
| Category | Score |
|---|---|
| Easy questions (1-5) | 5/5 β |
| Medium questions (6-10) | 5/5 β |
| Tricky questions (11-15) | 1.5/5 β οΈ |
| TOTAL | 11.5/15 = 77% |
Is this sufficient for hiv if not what else to be added
| Section | Status |
|---|---|
| Structure β gp120, gp41, p17, p24, 3 enzymes, diagram | β Perfect |
| Key points β Family, genome, enveloped RNA | β Perfect |
| Modes of transmission β Sexual, Blood, Vertical, Others | β Perfect |
| Pathogenesis flowchart β CD4 entry to AIDS | β Perfect |
| Clinical stages 1-4 with CD4 <200 | β Perfect |
| Opportunistic infections β TB, PCP, Candida | β Good |
| Lab diagnosis β ELISA β Western blot, p24, PCR | β Perfect |
| NACO strategies | β Perfect |
| HAART β mentioned | β Present |
HAART = combination of 3 drugs from 2 classes
Drug classes:
1. NRTIs (Nucleoside Reverse Transcriptase Inhibitors)
β Zidovudine (AZT), Lamivudine, Tenofovir
2. NNRTIs (Non-Nucleoside RTIs)
β Efavirenz, Nevirapine
3. Protease Inhibitors (PI)
β Lopinavir, Ritonavir
4. Integrase Inhibitors
β Raltegravir
5. Fusion Inhibitors
β Enfuvirtide (blocks gp41)
Standard 1st line in India (NACO):
TDF + 3TC + EFV
(Tenofovir + Lamivudine + Efavirenz)
PEP = given within 72 hours of exposure (needle stick, sexual assault)
Drug: TDF + 3TC + LPV/r (or TDF + 3TC + EFV)
Duration: 28 days
Must start ASAP β every hour counts
Window period = 3-12 weeks (antibodies not yet detectable)
β During window period: ELISA negative BUT patient is infectious!
β p24 antigen detectable BEFORE antibodies (earliest marker)
β HIV RNA (PCR) = most sensitive, detects in 1-2 weeks
Order of appearance:
HIV RNA (PCR) β p24 antigen β Anti-HIV antibodies
(earliest) (latest = ELISA detects this)
Opportunistic infections in AIDS (CD4 <200):
- TB (CD4 <350)
- Pneumocystis jirovecii pneumonia/PCP (CD4 <200)
- Oral candidiasis / Esophageal candidiasis
- Cryptococcal meningitis (CD4 <100)
- CMV retinitis (CD4 <50) β leads to blindness
- Toxoplasmosis of brain
- Kaposi's sarcoma (HHV-8 associated malignancy)
- MAC (Mycobacterium avium complex) (CD4 <50)
HIV-1 β Worldwide, more virulent, causes most infections globally
HIV-2 β West Africa, less virulent, slower progression to AIDS
| Missing Point | How Many Lines to Add |
|---|---|
| HAART drug classes + 1st line India | 6 lines |
| PEP β 72 hrs, duration, drugs | 3 lines |
| Window period + marker order | 4 lines |
| Full OI list (6-7 infections) | 7 lines |
| HIV-1 vs HIV-2 | 2 lines |
This is for microbiology hiv right
| Aspect | Microbiology HIV | Pharmacology HIV |
|---|---|---|
| Focus | The virus, how it infects, how to diagnose | The drugs used to treat it |
| Structure | gp120, gp41, p24, p17, 3 enzymes | Not needed |
| Pathogenesis | CD4 destruction, provirus, AIDS stages | Not needed |
| Transmission | Sexual, blood, vertical | Not needed |
| Lab diagnosis | ELISA, Western blot, PCR, p24 | Not needed |
| NACO | Yes β public health aspect | Not needed |
| HAART drug classes | Brief mention β what classes exist | Deep detail β MOA of each drug class |
| PEP | Yes β which drugs, duration | More detail on drug choice |
| Drug MOA | Not needed in detail | NRTIs, NNRTIs, PIs, Integrase inhibitors β full MOA |
As you already divided the 10 marks and 5 marks, um, you included all the 10 marks in the timetable for the three days timetable of micro, and you divided the 5 marks questions into read properly and, uh, read before the exam night. So, what you should do right now is, uh, divide what were the exact questions should I read in those timings. Like, you have to mention the timing and the question I have to read in that specific time for the-- those three days. Okay?
| Time | Question | Marks | What to Do |
|---|---|---|---|
| 6:30 - 8:00 AM | β | β | No study yet (Day 1 start) β eat, freshen up |
| 8:30 - 4:30 PM | Classes | β | Listen, attend |
| 5:00 - 6:00 PM | P1 Q5 β Sterilization & Disinfection | 10m | Read notes + write summary (you already did this β ) |
| 6:00 - 7:00 PM | P1 Q3 β ELISA | 5m | Read + write 1 page notes |
| 7:00 - 8:00 PM | Dinner + rest | β | β |
| 8:00 - 9:00 PM | P1 Q7 β HIV/AIDS (Part 1: Structure + Transmission + Pathogenesis) | 10m | Read + write |
| 9:00 - 10:00 PM | P1 Q7 β HIV/AIDS (Part 2: Clinical stages + Lab diagnosis + HAART + PEP + NACO) | 10m | Continue + complete notes |
| 10:00 - 10:15 PM | Break | β | β |
| 10:15 - 11:15 PM | P1 Q17 β Hepatitis A/B/C/D/E (Part 1: Classification + Hepatitis A + B morphology + serology markers) | 10m | Read + write |
| 11:15 PM - 12:15 AM | P1 Q17 β Hepatitis (Part 2: Hep C + D + E + prophylaxis of Hep B + comparison table) | 10m | Complete notes |
| 12:15 - 12:30 AM | Write 5 key points per topic in diary | β | HIV key points + Hepatitis key points |
| Time | Question | Marks | What to Do |
|---|---|---|---|
| 6:30 - 8:00 AM | Revise Day 1 topics | β | HIV + Hepatitis + Sterilization β read your written notes only |
| 8:30 - 4:30 PM | Classes | β | β |
| 5:00 - 6:00 PM | P1 Q4 β Hypersensitivity Reactions Type I, II, III, IV + Shwartzman | 10m | Read + write |
| 6:00 - 7:00 PM | P1 Q1 β Autoimmunity + SLE | 10m | Read + write |
| 7:00 - 8:00 PM | Dinner + rest | β | β |
| 8:00 - 9:00 PM | P1 Q6 β Typhoid/Enteric Fever (Pathogenesis + Widal test + Lab diagnosis) | 10m | Read + write |
| 9:00 - 10:00 PM | P2 Q12 β Tuberculosis (Pathogenesis + Ghon complex + TST + molecular methods) | 10m | Read + write |
| 10:00 - 10:15 PM | Break | β | β |
| 10:15 - 11:00 PM | P1 Q21 β Drug resistance mechanisms in bacteria | 10m | Read + write |
| 11:00 - 11:45 PM | P1 Q23 β Immune response + Cell mediated immunity + Active/Passive/Innate/Acquired | 10m | Read + write |
| 11:45 PM - 12:15 AM | P1 Q28 β Complement pathways (Classical + Alternative) | 5m | Read + write 1 page |
| 12:15 - 12:30 AM | Diary β 5 key points for Typhoid + TB | β | β |
| Time | Question | Marks | What to Do |
|---|---|---|---|
| 6:30 - 8:00 AM | Revise Day 2 topics | β | Hypersensitivity + Typhoid + TB β read written notes only |
| 8:30 - 4:30 PM | Classes | β | β |
| 5:00 - 5:45 PM | P2 Q7 β Streptococcus pyogenes | 10m | Read + write |
| 5:45 - 6:15 PM | P2 Q16 β Post-streptococcal complications (Rheumatic fever, PSGN) | 5m | Read + write |
| 6:15 - 7:00 PM | P2 Q2 β Diphtheria | 10m | Read + write |
| 7:00 - 8:00 PM | Dinner + rest | β | β |
| 8:00 - 8:45 PM | P2 Q11 β Syphilis (Primary + Secondary + Lab diagnosis + RPR) | 10m | Read + write |
| 8:45 - 9:15 PM | P2 Q1 β Gonorrhea + STI classification | 10m | Read + write |
| 9:15 - 10:00 PM | P2 Q8 β Bacterial Meningitis (Lab diagnosis + TB meningitis + Cryptococcal) | 10m | Read + write |
| 10:00 - 10:15 PM | Break | β | β |
| 10:15 - 11:00 PM | 5-mark proper study batch 1: P1 Q37 Cholera + P1 Q31 MRSA | 5m each | 25 min each |
| 11:00 - 11:45 PM | 5-mark proper study batch 2: P2 Q3 Rabies + PEP + P2 Q14 Tetanus | 5m+10m | Read + 1 page each |
| 11:45 PM - 12:15 AM | 5-mark proper study batch 3: P1 Q9 Malaria + P2 Q25 Cerebral Malaria (do together) | 10m | Read + 1 page |
| 12:15 - 12:30 AM | Diary β 5 key points for Syphilis + Meningitis | β | β |
| Paper | Q# | Topic |
|---|---|---|
| P1 | Q8 | Dengue |
| P1 | Q10 | Leishmaniasis |
| P1 | Q11 | Filariasis |
| P1 | Q12 | Entamoeba Histolytica |
| P1 | Q13 | Giardia |
| P1 | Q14 | Leptospirosis |
| P1 | Q15 | Taenia Solium |
| P1 | Q16 | Ascaris + Hookworm (P1 Q24) |
| P1 | Q18 | Enrichment + Selective media |
| P1 | Q19 | Herpes zoster |
| P1 | Q20 | Campylobacter |
| P1 | Q22 | Diarrhoeagenic E. coli |
| P1 | Q25 | Dermatophytes |
| P1 | Q26 | Hand hygiene moments |
| P1 | Q27 | Anaerobic culture |
| P1 | Q29 | Lab diagnosis viral + fungal |
| P1 | Q30 | Brucellosis + Kala azar |
| P1 | Q32 | Blood culture + Infective Endocarditis |
| P1 | Q33 | IgM, IgA, IgG |
| P1 | Q34 | Amoebic liver abscess |
| P1 | Q35 | Allograft + GVHD |
| P1 | Q36 | Cysticercus Cellulosae |
| P1 | Q38 | Varicella zoster |
| P1 | Q39 | Actinomycosis + Mycetoma |
| P1 | Q40 | Leprosy |
| P1 | Q41 | Larva migrans |
| P1 | Q42 | Toxic shock syndrome |
| P1 | Q43 | Viral gastroenteritis |
| P1 | Q46 | Enterobius |
| P1 | Q47 | H. pylori |
| P1 | Q48 | Staph food poisoning |
| P1 | Q49 | Pasteur + Koch |
| P1 | Q50 | Universal precautions |
| P2 | Q4 | Polio + OPV vs IPV |
| P2 | Q5 | Influenza + H1N1 |
| P2 | Q9 | Echinococcus |
| P2 | Q10 | UTI |
| P2 | Q13 | Plague |
| P2 | Q15 | COVID-19 |
| P2 | Q17 | Satellitism |
| P2 | Q18 | Pneumocystis |
| P2 | Q19 | Anaerobic vaginosis |
| P2 | Q20 | LGV |
| P2 | Q22 | Anthrax |
| P2 | Q23 | Aspergillosis |
| P2 | Q24 | Slow viral infections |
| P2 | Q26 | Neurocysticercosis |
| P2 | Q27 | Chancroid |
| P2 | Q28 | Acute Pyelonephritis |
| P2 | Q29 | Naegleria |
| P2 | Q30 | Infection control |
| P2 | Q31 | Elek's test |
| P2 | Q32 | Toxoplasma |
| P2 | Q33 | Trichomonas |
| P2 | Q34 | Primary amoebic encephalitis |
| P2 | Q35 | Mycoplasma/Atypical pneumonia |
| P2 | Q36 | Oncogenic viruses |
| P2 | Q37 | Histoplasmosis |
| P2 | Q38 | Viral hemorrhagic fevers |
| P2 | Q40 | Japanese B Encephalitis |
| P2 | Q41 | Paragonimiasis |
| P2 | Q42 | Prions |
| P2 | Q43 | NGU |
| P2 | Q44 | Borrelia Vincenti |
| P2 | Q45 | Brucellosis |
| P2 | Q46 | Zygomycosis |
| P2 | Q47 | Congenital rubella |
| P2 | Q48 | Tularemia |
| P2 | Q49 | Mumps |
| P2 | Q50 | Pertussis |
Give these, uh, you give, um, read... Before the exam, they made a list, no? Those list, in those list, you gave some questions, right? So, what you should do right now is, night before exam, uh, list was there, right? That list, give it in the priority wise, all the questions. Just give it in the priority wise, these read before exam list.
| # | Paper | Q# | Topic | Why High Priority |
|---|---|---|---|---|
| 1 | P1 | Q8 | Dengue | Very common, clinical case type |
| 2 | P2 | Q4 | Polio + OPV vs IPV | Frequently asked comparison |
| 3 | P2 | Q5 | Influenza + Swine flu + H1N1 | Current relevance, common |
| 4 | P1 | Q34 | Amoebic liver abscess | Classic case question |
| 5 | P2 | Q10 | UTI β lab diagnosis | Practical/clinical, very common |
| 6 | P1 | Q33 | IgM, IgA, IgG β structure + functions | Immunology favourite |
| 7 | P2 | Q22 | Bacillus anthracis β Anthrax | Bioterrorism angle, examiner favourite |
| 8 | P2 | Q18 | Pneumocystis pneumonia | AIDS opportunistic infection link |
| 9 | P1 | Q12 | Entamoeba Histolytica | Classic parasite, easy marks |
| 10 | P2 | Q23 | Aspergillosis | Common fungal, immunocompromised |
| # | Paper | Q# | Topic | Why |
|---|---|---|---|---|
| 11 | P1 | Q15 | Taenia Solium | Appears in BOTH papers (P1 Q15 = P2 Q6) |
| 12 | P1 | Q16 | Ascaris lumbricoides | Most common helminth worldwide |
| 13 | P1 | Q24 | Hookworm (case-based) | Case-based = easy to answer if you know life cycle |
| 14 | P2 | Q45 | Brucellosis + lab diagnosis | Also in P1 Q30 β double coverage |
| 15 | P2 | Q9 | Echinococcus granulosus | Cestode classification asked often |
| 16 | P1 | Q19 | Herpes zoster | Herpes group = common viva |
| 17 | P1 | Q38 | Varicella zoster | Same virus as above β study both together |
| 18 | P2 | Q13 | Plague (= P2 Q21 Yersinia) | Two questions, one topic |
| 19 | P1 | Q40 | Leprosy + lab diagnosis | ZN stain connection, Indian relevance |
| 20 | P2 | Q35 | Atypical pneumonia / Mycoplasma | "Walking pneumonia" β classic |
| # | Paper | Q# | Topic |
|---|---|---|---|
| 21 | P1 | Q13 | Giardia lamblia |
| 22 | P1 | Q11 | Bancroftian Filariasis |
| 23 | P1 | Q10 | Leishmaniasis / Kala azar |
| 24 | P1 | Q14 | Leptospirosis |
| 25 | P1 | Q18 | Enrichment media + Selective media |
| 26 | P1 | Q27 | Anaerobic culture methods |
| 27 | P1 | Q29 | Lab diagnosis of viral + fungal infections |
| 28 | P1 | Q32 | Blood culture β Infective Endocarditis |
| 29 | P1 | Q35 | Allograft reaction + GVHD |
| 30 | P1 | Q42 | Toxic shock syndrome |
| 31 | P2 | Q15 | COVID-19 pathogenesis |
| 32 | P2 | Q36 | Oncogenic viruses |
| 33 | P2 | Q38 | Viral hemorrhagic fevers |
| 34 | P2 | Q40 | Japanese B Encephalitis |
| 35 | P2 | Q46 | Zygomycosis + Opportunistic mycoses |
| 36 | P2 | Q47 | Congenital rubella syndrome |
| # | Paper | Q# | Topic |
|---|---|---|---|
| 37 | P1 | Q20 | Campylobacter |
| 38 | P1 | Q22 | Diarrhoeagenic E. coli |
| 39 | P1 | Q25 | Dermatophytes |
| 40 | P1 | Q26 | Hand hygiene moments |
| 41 | P1 | Q36 | Cysticercus Cellulosae |
| 42 | P1 | Q39 | Actinomycosis + Mycetoma |
| 43 | P1 | Q41 | Larva migrans |
| 44 | P1 | Q43 | Viral gastroenteritis |
| 45 | P1 | Q46 | Enterobius vermicularis |
| 46 | P1 | Q47 | H. pylori |
| 47 | P1 | Q48 | Staph food poisoning (Chinese rice) |
| 48 | P1 | Q49 | Louis Pasteur + Robert Koch |
| 49 | P1 | Q50 | Universal precautions |
| 50 | P2 | Q17 | Satellitism |
| 51 | P2 | Q19 | Anaerobic vaginosis |
| 52 | P2 | Q20 | LGV |
| 53 | P2 | Q24 | Slow viral infections |
| 54 | P2 | Q26 | Neurocysticercosis |
| 55 | P2 | Q27 | Chancroid |
| 56 | P2 | Q28 | Acute Pyelonephritis |
| 57 | P2 | Q29 | Naegleria fowleri |
| 58 | P2 | Q30 | Infection control policy |
| 59 | P2 | Q31 | Elek's gel test |
| 60 | P2 | Q32 | Toxoplasma gondii |
| 61 | P2 | Q33 | Trichomonas vaginalis |
| 62 | P2 | Q34 | Primary amoebic encephalitis |
| 63 | P2 | Q37 | Histoplasmosis |
| 64 | P2 | Q41 | Paragonimiasis |
| 65 | P2 | Q42 | Prions |
| 66 | P2 | Q43 | NGU |
| 67 | P2 | Q44 | Borrelia Vincenti |
| 68 | P2 | Q48 | Tularemia |
| 69 | P2 | Q49 | Mumps |
| 70 | P2 | Q50 | Pertussis |
| Time | What to Read |
|---|---|
| 10:15 PM - 11:00 PM | Priority 1 (Q1-10) β 4-5 mins each |
| 11:00 PM - 11:45 PM | Priority 2 (Q11-20) β 3-4 mins each |
| 11:45 PM - 12:15 AM | Priority 3 (Q21-36) β 1-2 mins each (just headings) |
| 12:15 AM onwards | Sleep. Priority 4 is NOT worth losing sleep over. |
Is this enough for Hypersensitivity Reactions anything extra to add??
| Section | Status |
|---|---|
| Type 1 β IgE, 2 phases, mast cell degranulation, mechanism diagram | β Perfect |
| Type 1 β Preformed + newly synthesized mediators | β Perfect |
| Type 1 β Clinical features (mild + severe), lab diagnosis | β Perfect |
| Type 1 β Examples (Eczema, Asthma, Anaphylaxis etc.) | β Perfect |
| Type 2 β Cytotoxic, IgG/IgM, complement, phagocytosis | β Perfect |
| Type 2 β Examples mnemonic "My Blood Group Is RH Positive" | β Excellent |
| Type 3 β Immune complex, C3a/C5a, membrane attack complex | β Perfect |
| Type 3 β Examples mnemonic "SHARP" | β Excellent |
| Type 4 β T cell mediated, no antibody, slow response | β Perfect |
| Type 4 β IFN-Ξ³, IL-1,2, TNF-Ξ± β Granuloma formation | β Perfect |
| Type 4 β Examples, lab diagnosis (patch test, TST, biopsy) | β Perfect |
| Summary β Types 1,2,3 = B cell / Type 4 = T cell | β Perfect |
| Mnemonics for all 4 types | β Excellent |
Shwartzman Reaction β NOT a true hypersensitivity
Two types:
1. Local Shwartzman reaction
- 1st injection of endotoxin (gram -ve bacteria) β skin
- 2nd injection 24 hrs later β same site
- Result: Hemorrhagic necrosis at site
2. Generalized Shwartzman reaction
- 1st injection β IV endotoxin
- 2nd injection β IV endotoxin 24 hrs later
- Result: Bilateral renal cortical necrosis + DIC
Key feature: NOT immunological (no antibodies, no sensitization)
Mechanism: Fibrin deposits + neutrophil plugging of vessels
Classic example: Meningococcal septicemia β Waterhouse-Friderichsen syndrome
| Feature | Type 1 | Type 2 | Type 3 | Type 4 |
|---|---|---|---|---|
| Name | Anaphylactic | Cytotoxic | Immune complex | Delayed/DTH |
| Antibody | IgE | IgG/IgM | IgG/IgM | None |
| Cells | Mast cells, Basophils | NK cells, Phagocytes | Neutrophils | T cells, Macrophages |
| Time | Minutes | Hours | 6-8 hrs | 48-72 hrs |
| Complement | No | Yes | Yes | No |
| Key example | Anaphylaxis | Myasthenia gravis | Serum sickness | TB tuberculin test |
Add: Rh incompatibility β Hemolytic disease of newborn (HDN/Erythroblastosis fetalis)
This is THE classic Type 2 example in every exam
| Missing | Lines to Add |
|---|---|
| Shwartzman reaction (local + generalized) | 8 lines |
| Comparison table (all 4 types) | 5 rows |
| HDN/Erythroblastosis fetalis in Type 2 examples | 1 line |
Make a summary flow chart for both hiv and Hypersensitivity Reactions from the extra topics you added and from my notes too
HIV/AIDS
β
βββ STRUCTURE
β βββ Family: Retroviridae (Lentivirus)
β βββ Enveloped RNA virus β 2 copies ssRNA
β βββ Envelope proteins:
β β βββ gp120 β Surface spikes (binds CD4)
β β βββ gp41 β Transmembrane (fusion)
β βββ Core proteins:
β β βββ p24 β Capsid (earliest detectable antigen)
β β βββ p17 β Matrix protein
β βββ 3 Enzymes:
β βββ Reverse transcriptase (RNAβDNA)
β βββ Integrase (inserts into host genome)
β βββ Protease (cleaves viral proteins)
β
βββ SEROTYPES
β βββ HIV-1 β Worldwide, more virulent, most infections
β βββ HIV-2 β West Africa only, less virulent, slower AIDS progression
β
βββ TRANSMISSION (SBVO)
β βββ S β Sexual (most common)
β βββ B β Blood β transfusion, IV drug use, needle stick
β βββ V β Vertical β mother to child (pregnancy/delivery/breast milk)
β βββ O β Others β organ transplant (rare)
β
βββ PATHOGENESIS
β β
β βββ HIV enters via mucosa/blood
β β β
β βββ Binds CD4+ T cells via gp120 + CD4 receptor + CCR5/CXCR4
β β β
β βββ Fusion via gp41 β enters cell
β β β
β βββ Reverse transcription β RNA β DNA (provirus)
β β β
β βββ Integrase β integrates into HOST genome (stays forever)
β β β
β βββ Viral replication + budding
β β β
β βββ CD4+ T cell destruction
β β β
β βββ Progressive immunodeficiency
β β β
β βββ Opportunistic infections + Malignancies β AIDS
β
βββ CLINICAL STAGES
β βββ Stage 1 β Acute phase (2-4 weeks)
β β βββ Fever, rash, lymphadenopathy (flu-like)
β βββ Stage 2 β Asymptomatic phase
β β βββ Clinically silent, CD4 slowly falling
β βββ Stage 3 β Persistent Generalized Lymphadenopathy (PGL)
β βββ Stage 4 β AIDS (CD4 <200)
β βββ Opportunistic infections:
β β βββ TB (CD4 <350)
β β βββ PCP β Pneumocystis jirovecii (CD4 <200)
β β βββ Oral/Esophageal Candidiasis
β β βββ Cryptococcal meningitis (CD4 <100)
β β βββ CMV Retinitis β blindness (CD4 <50)
β β βββ Toxoplasmosis of brain
β β βββ MAC β Mycobacterium avium complex (CD4 <50)
β βββ Malignancies:
β β βββ Kaposi's sarcoma (HHV-8)
β βββ Symptoms: Weight loss, chronic diarrhoea, fever
β
βββ LAB DIAGNOSIS
β β
β βββ WINDOW PERIOD = 3-12 weeks
β β βββ β οΈ ELISA negative BUT patient is INFECTIOUS
β β
β βββ Marker order (earliest β latest):
β β HIV RNA (PCR) β p24 antigen β Anti-HIV antibodies
β β
β βββ 1. Screening tests:
β β βββ ELISA / Rapid tests β detects ANTIBODIES
β β
β βββ 2. If ELISA +ve β Confirmatory:
β β βββ Western Blot / Line Immunoassay
β β
β βββ 3. Early detection (window period):
β β βββ p24 antigen detection
β β βββ PCR (HIV RNA) β MOST SENSITIVE
β β
β βββ 4. Monitoring:
β βββ CD4 count β disease progression
β βββ Viral load (RNA PCR) β treatment response
β
βββ TREATMENT β HAART
β βββ = Highly Active Antiretroviral Therapy
β βββ Combination of 3 drugs from 2 classes
β βββ Drug classes:
β β βββ NRTIs β Zidovudine (AZT), Lamivudine, Tenofovir
β β βββ NNRTIs β Efavirenz, Nevirapine
β β βββ Protease Inhibitors β Lopinavir, Ritonavir
β β βββ Integrase Inhibitors β Raltegravir
β β βββ Fusion Inhibitors β Enfuvirtide (blocks gp41)
β βββ 1st line India (NACO): TDF + 3TC + EFV
β
βββ PEP (Post Exposure Prophylaxis)
β βββ Given within 72 HOURS of exposure
β βββ Drug: TDF + 3TC + LPV/r
β βββ Duration: 28 DAYS
β βββ Start ASAP β every hour counts
β
βββ NACO STRATEGIES (6 points)
βββ 1. Awareness + Education programs
βββ 2. Safe sex promotion (condoms)
βββ 3. Blood safety (donor screening)
βββ 4. PPTCT β Prevention of Parent to Child Transmission
βββ 5. Free ART centres
βββ 6. Targeted interventions (high risk groups)
HYPERSENSITIVITY REACTIONS
β
βββ CLASSIFICATION (Gell & Coombs)
β βββ Type 1 β Anaphylactic (IgE mediated)
β βββ Type 2 β Cytotoxic (IgG/IgM mediated)
β βββ Type 3 β Immune Complex (IgG/IgM mediated)
β βββ Type 4 β Delayed/DTH (T cell mediated)
β
β Types 1, 2, 3 = Antibody (B cell) mediated
β Type 4 = Cellular (T cell) mediated
β
β
βββ TYPE 1 β ANAPHYLACTIC
β βββ Key: IgE, Immediate, Rapid, Mast cells
β β
β βββ PHASE 1 β Sensitization (1st exposure):
β β Allergen β APC β TH2 cells
β β β Cytokines (IL-4, IL-5, IL-3)
β β β B cells β Plasma cells β IgE production
β β β IgE attaches to Fc receptors on MAST CELLS
β β
β βββ PHASE 2 β Effector (2nd exposure):
β β Allergen β directly binds IgE on mast cells
β β β Cross-linking β DEGRANULATION
β β β Release of mediators
β β
β βββ MEDIATORS:
β β βββ Preformed: Histamine, Proteases, Serotonin
β β βββ Newly synthesized: PGD2, Leukotrienes, Cytokines, PAF
β β
β βββ CLINICAL:
β β βββ Localized (Atopy): Allergic rhinitis, Urticaria,
β β β Conjunctivitis, Eczema, Asthma
β β βββ Systemic: Anaphylactic shock (most severe)
β β
β βββ EXAMPLES: Hay fever, Asthma, Urticaria, Eczema,
β β Anaphylaxis, Theobald Smith, PK reaction,
β β Casoni's skin test, Schultz-Dale phenomenon
β β
β βββ LAB: Skin prick test (wheal+flare), Serum IgE (ELISA),
β Basophil activation test
β
β
βββ TYPE 2 β CYTOTOXIC
β βββ Key: IgG/IgM, targets HOST CELL surface antigens
β β
β βββ MECHANISM:
β β Antigen on target cell β B cell β Plasma β IgG/IgM
β β β Complement activation β C3b (opsonin)
β β β Phagocyte engulfs HOST CELL (PHAGOCYTOSIS)
β β
β βββ EXAMPLES β Mnemonic: "My Blood Group Is RH Positive"
β β βββ My β Myasthenia Gravis
β β βββ Blood β Blood transfusion reactions
β β βββ Group β Goodpasture syndrome + Grave's disease
β β βββ Is β Insulin resistant diabetes + ITP
β β βββ R β Rheumatic fever
β β βββ H β Hyperacute graft rejection
β β βββ Positive β Pernicious anemia + Pemphigus vulgaris
β β + HDN/Erythroblastosis fetalis (Rh incompatibility) β
β β
β βββ Complement involved: YES
β
β
βββ TYPE 3 β IMMUNE COMPLEX
β βββ Key: Soluble antigen-antibody complexes, IgG/IgM
β β
β βββ MECHANISM:
β β Soluble antigen β B cell β Plasma β IgG/IgM
β β β Antigen-Antibody COMPLEXES form
β β β C5-9 Membrane attack complex
β β β C3a, C5a β Proinflammatory mediators
β β β Histamine β β Vascular permeability β Edema
β β β Neutrophil infiltration β Inflammation + Tissue damage
β β
β βββ EXAMPLES β Mnemonic: "SHARP"
β β βββ S β Serum sickness, Schick test, SLE
β β βββ H β Henoch-Schonlein Purpura
β β βββ A β Arthus reaction
β β βββ R β Reactive arthritis, Raji assay
β β βββ P β Polyarteritis nodosa (PAN) + PSGN
β β
β βββ Complement involved: YES
β
β
βββ TYPE 4 β DELAYED (DTH)
β βββ Key: T cell mediated, NO antibody, 48-72 hrs
β β
β βββ MECHANISM:
β β Non-degradable antigen β APC β TH1 cells
β β TH1 releases 3 cytokines:
β β βββ IFN-Ξ³ β monocytes out of blood β Macrophages
β β β β Epithelioid cells β Fuse β GIANT CELLS
β β βββ IL-1, IL-2 β activates T lymphocytes
β β βββ TNF-Ξ± β activates Fibroblasts
β β Giant cell + T lymphocyte + Fibroblast β GRANULOMA
β β
β βββ MEDIATORS: IFN-Ξ³, TNF-Ξ±, IL-1, IL-2
β β + Macrophages + CD8 T cells β ROS β tissue damage
β β
β βββ EXAMPLES β Mnemonic: "John Tulep Contact Hashimoto"
β β βββ Tuberculin rxn (Mantoux test)
β β βββ Contact dermatitis
β β βββ Hashimoto thyroiditis
β β βββ John Mote rxn
β β βββ Le Promin rxn (Lepromin test)
β β
β βββ LAB: Patch test, Tuberculin skin test, Biopsy
β
β
βββ β SHWARTZMAN REACTION (Added β exam specific)
β βββ NOT a true hypersensitivity β NO immunological memory
β β
β βββ LOCAL Shwartzman:
β β 1st injection endotoxin β skin
β β 2nd injection 24 hrs later β SAME site
β β Result β Hemorrhagic necrosis at site
β β
β βββ GENERALIZED Shwartzman:
β β 1st injection β IV endotoxin
β β 2nd injection β IV endotoxin (24 hrs later)
β β Result β Bilateral renal cortical necrosis + DIC
β β
β βββ Mechanism: Fibrin deposits + neutrophil plugging
β βββ Classic example: Meningococcal septicemia
β β Waterhouse-Friderichsen syndrome
β
β
βββ COMPARISON TABLE (MCQ gold)
Feature | Type 1 | Type 2 | Type 3 | Type 4
-----------|-----------|-------------|----------------|----------
Name | Anaphyl. | Cytotoxic | Immune complex | Delayed
Antibody | IgE | IgG/IgM | IgG/IgM | NONE
Cells | Mast/Baso | NK/Phago | Neutrophils | T cells/Macro
Timing | Minutes | Hours | 6-8 hrs | 48-72 hrs
Complement | NO | YES | YES | NO
Key eg | Anaphyl. | MG/HDN | Serum sickness | TB test
A β Anaphylactic (Type 1) β Allergy β IgE
C β Cytotoxic (Type 2) β Cell surface β IgG/IgM
I β Immune complex (Type 3) β Inflammation β IgG/IgM
D β Delayed (Type 4) β DTH β T cells
Give mcqs on hiv first
| Q | Your Answer | Correct | Result | Explanation |
|---|---|---|---|---|
| 1 | B | B | β | Retroviridae β Lentivirus |
| 2 | C | C | β | gp120 binds CD4 |
| 3 | C | C | β | gp41 = fusion protein |
| 4 | D | D | β | Reverse transcriptase = RNAβDNA |
| 5 | B | B | β | CCR5 and CXCR4 β perfect |
| 6 | C | C | β | Sexual = most common |
| 7 | C | C | β | CD4 <200 = AIDS |
| 8 | C | C | β | Window period = ELISA negative but INFECTIOUS |
| 9 | C | C | β | HIV RNA PCR = earliest |
| 10 | D | D | β | PCR = most sensitive |
| 11 | B | B | β | Western blot = confirmatory |
| 12 | β | C | β | CMV retinitis occurs at CD4 <50 (lowest threshold) |
| 13 | C | C | β | HHV-8 β Kaposi's sarcoma |
| 14 | C | C | β | PEP within 72 hours |
| 15 | B | B | β | TDF + 3TC + EFV = NACO 1st line |
CD4 COUNT β OPPORTUNISTIC INFECTION
β
βββ <350 β Tuberculosis (TB)
βββ <200 β Pneumocystis jirovecii pneumonia (PCP)
β Oral Candidiasis
βββ <100 β Cryptococcal meningitis
β Toxoplasmosis of brain
βββ <50 β CMV Retinitis β Q12 answer
MAC (Mycobacterium avium complex)
| Category | Score |
|---|---|
| Structure questions (1-4) | 4/4 β |
| Pathogenesis (5-8) | 4/4 β |
| Lab diagnosis (9-11) | 3/3 β |
| Clinical/Treatment (12-15) | 2/3 β οΈ |
| TOTAL | 13/15 = 87% |
Let's go with hepatitis now
| Virus | Family | Genome | Envelope | Transmission |
|---|---|---|---|---|
| HAV | Picornaviridae | +ssRNA | β No | Fecal-oral |
| HBV | Hepadnaviridae | dsDNA (partial) | β Yes | Parenteral, sexual, vertical |
| HCV | Flaviviridae | +ssRNA | β Yes | Parenteral, sexual |
| HDV | Deltaviridae | Circular RNA | β Yes (HBsAg) | Parenteral, sexual |
| HEV | Hepeviridae | +ssRNA | β No | Fecal-oral |
"ABCDE β Oral Oral Blood Blood Blood" β wait, simpler: A and E = fEcal-oral (both vowels = gut route) B, C, D = Blood/parenteral
| Feature | HAV | HBV | HCV | HDV | HEV |
|---|---|---|---|---|---|
| Common name | Infectious | Serum | Non-A non-B | Delta agent | Enteric non-A non-B |
| Onset | Abrupt | Insidious | Insidious | Abrupt | Abrupt |
| Incubation | 15-50 days | 45-160 days | 14-180 days | 15-64 days | 15-50 days |
| Chronicity | β No | β Yes | β Yes (70%!) | β Yes | β No |
| Carrier state | β No | β Yes | β Yes | β Yes | β No |
| Cirrhosis/HCC | β No | β Yes | β Yes | β Yes | β No |
| Severity | Mild | Moderate | Subclinical | Severe (superinfection) | Mild (severe in pregnancy) |
| Mortality | <0.5% | 1-2% | ~4% | High | 1-2% (20% pregnant) |
| Vaccine | β Available | β Available | β No | HBV vaccine covers HDV | β Available |
HBV = Dane particle = 42 nm diameter
βββ Outer envelope β contains HBsAg (surface antigen)
β βββ 3 glycoproteins: L (gp42), M (gp36), S (gp27)
βββ Inner capsid β contains HBcAg (core antigen)
βββ Genome β partially double stranded circular DNA (3200 bases)
βββ Enzymes β Reverse transcriptase + DNA polymerase
(replicates via RNA intermediate β unique for DNA virus!)
HBsAg was originally called Australia antigen β first discovered in Australian aboriginal blood
| Marker | What it means | When present |
|---|---|---|
| HBsAg | Surface antigen β first to appear | Active infection (acute + chronic) |
| Anti-HBs | Antibody to surface antigen | Recovery β OR after vaccination β |
| HBcAg | Core antigen | Inside liver cells only (not in serum) |
| Anti-HBc IgM | IgM antibody to core | ACUTE infection β best marker of acute HBV |
| Anti-HBc IgG | IgG antibody to core | Past infection or chronic |
| HBeAg | "e" antigen | HIGH infectivity, active viral replication |
| Anti-HBe | Antibody to "e" antigen | Declining infectivity, resolving infection |
| HBV DNA | Viral DNA in serum | Most sensitive β active replication |
HBsAg disappears β Anti-HBs not yet appeared
= WINDOW PERIOD
During this time β Anti-HBc IgM is the ONLY detectable marker
This is why Anti-HBc IgM = marker of ACUTE HBV infection
| Scenario | HBsAg | Anti-HBs | Anti-HBc | HBeAg |
|---|---|---|---|---|
| Acute infection | β | β | IgM β | β |
| Window period | β | β | IgM β | β |
| Recovery | β | β | IgG β | β |
| Vaccination | β | β | β | β |
| Chronic carrier | β | β | IgG β | Β± |
Key MCQ: How to differentiate recovery from vaccination? Recovery = Anti-HBs + Anti-HBc both positive Vaccination = Anti-HBs positive ONLY (no Anti-HBc)
1. PASSIVE immunization:
β HBIG (Hepatitis B Immunoglobulin)
β Given after exposure (needle stick, neonate of HBsAg+ mother)
β Gives immediate but temporary protection
2. ACTIVE immunization (Vaccine):
β Recombinant vaccine (HBsAg produced in yeast)
β Schedule: 0, 1, 6 months (3 doses)
β Part of Universal Immunization Program in India
β For newborns of HBsAg+ mothers: HBIG + vaccine at birth
3. Anti-HBs titre >10 mIU/mL = protected
HCV key facts:
βββ Family: Flaviviridae, +ssRNA, enveloped
βββ 70 million chronic carriers worldwide
βββ 70% cases become CHRONIC (highest chronicity of all hepatitis)
βββ Leads to β cirrhosis β hepatocellular carcinoma
βββ NO vaccine available β
βββ Lab diagnosis: Anti-HCV ELISA β confirm by HCV RNA PCR
βββ Treatment: Direct Acting Antivirals (DAAs) β sofosbuvir
High cure rates (>95%)
HDV key facts:
βββ DEFECTIVE virus β cannot replicate alone
βββ NEEDS HBV for its envelope (uses HBsAg as its coat)
βββ Two types of infection:
β βββ Co-infection: HDV + HBV together at same time
β β β Usually self-limiting
β βββ Superinfection: HDV infects existing HBV carrier
β β SEVERE, often leads to fulminant hepatitis
βββ Prevention: HBV vaccine automatically prevents HDV too
HEV key facts:
βββ Fecal-oral transmission (like HAV)
βββ NO chronic infection, NO carrier state
βββ Special feature: SEVERE in pregnant women
β β Mortality 20% in pregnancy (vs 1-2% in normal)
β β Causes fulminant hepatic failure in 3rd trimester
βββ Major outbreaks in India after floods/contaminated water
βββ No specific treatment β supportive only
HEPATITIS VIRUSES
β
βββ FECAL-ORAL (A & E)
β βββ HAV β mild, no chronicity, abrupt, vaccine available
β βββ HEV β mild except PREGNANCY (20% mortality), no chronicity
β
βββ PARENTERAL/BLOOD (B, C, D)
βββ HBV β Dane particle, DNA virus, HBsAg/HBeAg markers
β Chronic 3-10%, vaccine available, causes HCC
β
βββ HCV β RNA, Flavivirus, 70% chronic, NO vaccine
β Leads to cirrhosis + HCC, treated with DAAs
β
βββ HDV β Defective, needs HBV, delta agent
Superinfection = most severe
Prevented by HBV vaccine
A = picornA (Picornaviridae)
B = hepadnaB (Hepadnaviridae)
C = flavivirusC (Flaviviridae)
D = deltaD (Deltaviridae)
E = hepEvirus (Hepeviridae)
"C Before D Before B"
HCV = 70% β HDV = Yes β HBV = 3-10%
A and E = NEVER chronic
S = HBsAg (Surface β first to appear)
e = HBeAg (infectivity marker)
C = HBcAg (Core β window period marker = anti-HBc IgM)
B = Anti-HBs (last β recovery/vaccine)
HEV in pregnancy = 20% mortality β only hepatitis dangerous in pregnancy
Explain serology patterns in easy way
| Marker | Plain English |
|---|---|
| HBsAg | The virus is PRESENT in your blood right now |
| Anti-HBs | Your body DEFEATED the virus (or you got vaccinated) |
| HBcAg | Core of the virus β stays inside liver, never in blood |
| Anti-HBc IgM | Your body just FOUND OUT about the infection (recent/acute) |
| Anti-HBc IgG | Your body SAW this virus before (past infection) |
| HBeAg | Virus is ACTIVELY multiplying β highly infectious |
| Anti-HBe | Virus slowing down β less infectious |
What's happening: Virus entered, multiplying fast
Body's response: Just started fighting
HBsAg β
(virus is here)
HBeAg β
(virus multiplying like crazy)
Anti-HBc β
IgM (body just discovered it β ACUTE marker)
Anti-HBs β (body hasn't won yet)
Anti-HBe β (virus still active)
Think: "Virus arrived, body fighting, no winner yet"
What's happening: HBsAg disappeared BUT Anti-HBs not yet made
Body's response: In between β transition phase
HBsAg β (virus cleared from surface)
Anti-HBs β (not made yet)
Anti-HBc β
IgM ONLY β ONLY marker present!
HBeAg β
Anti-HBe β
Think: "Both virus AND antibody gone β only Anti-HBc IgM standing" This is why Anti-HBc IgM = WINDOW PERIOD marker
What's happening: Body won. Virus cleared. Memory cells formed.
HBsAg β (virus gone)
Anti-HBs β
(body made protective antibody β WON)
Anti-HBc β
IgG (memory of past infection)
HBeAg β
Anti-HBe β
(virus activity stopped)
Think: "Body won the fight, keeping memory (Anti-HBc IgG) and shield (Anti-HBs)"
What's happening: Got HBsAg vaccine β body made antibody
WITHOUT ever seeing the real virus
HBsAg β (never infected)
Anti-HBs β
(vaccine worked β protected)
Anti-HBc β (never saw real virus β NO core antibody)
HBeAg β
Anti-HBe β
Think: "Shortcut to protection β Anti-HBs YES but Anti-HBc NO"
What's happening: Body failed to clear virus. Virus living permanently.
HBsAg β
(virus still present β for >6 months = chronic)
Anti-HBs β (body never won)
Anti-HBc β
IgG (been there for a long time)
HBeAg Β± (may or may not be multiplying)
Anti-HBe Β±
Think: "Virus refused to leave. Body gave up fighting."
RECOVERY = Anti-HBs β
+ Anti-HBc β
VACCINATION = Anti-HBs β
+ Anti-HBc β
The difference = Anti-HBc
If Anti-HBc present β person SAW the real virus (recovered)
If Anti-HBc absent β person only got vaccine (never infected)
Stage HBsAg Anti-HBs Anti-HBc HBeAg Anti-HBe
βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
Acute β
β IgM β
β
β
Window β β IgM β
β β
Recovery β β
IgG β
β β
Vaccination β β
β β β
Chronic β
β IgG β
Β± Β±
βββββββββββββββββββββββββββββββββββββββββββββββββββββββββββββ
S β HBsAg appears FIRST (Surface antigen)
A β HBeAg appears (Active replication)
V β (V for Versus) β window period, Anti-HBc alone
E β Anti-HBs appears LAST (End = recovery/vaccine)
So when the virus entered in the body hbsag leaves and roams in blood and the core enters liver is that it??
I couldn't get to follow the schedule correctly today's july 6th and i completed only Sterilization, hiv and hepatitis what should i do now